Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Tuberculosis

  Free Subscription


Articles published in Int J Tuberc Lung Dis

Retrieve available abstracts of 410 articles:
HTML format
Text format



Single Articles


    October 2018
  1. COMSTOCK D, Khorolsky C, Galbraith R
    Severe rifamycin-induced immune thrombocytopenia in a patient with extra-pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:1243-1244.
    PubMed     Text format    


  2. SETO J, Wada T, Suzuki Y, Ikeda T, et al
    A case of laboratory cross-contamination of Mycobacterium tuberculosis identified using comparative genomics.
    Int J Tuberc Lung Dis. 2018;22:1239-1242.
    PubMed     Text format     Abstract available


  3. WANG Y, Wang L, Wen Z, Wang J, et al
    High IL-6 and VEGF-A levels correlate with delayed wound healing in cervical lymph node tuberculosis patients.
    Int J Tuberc Lung Dis. 2018;22:1227-1232.
    PubMed     Text format     Abstract available


  4. ALARCON V, Alarcon-Arrascue E, Mendoza-Ticona A, Obregon G, et al
    Programmatic management of patients with pre-extensively drug-resistant tuberculosis in Peru, 2011-2014.
    Int J Tuberc Lung Dis. 2018;22:1220-1226.
    PubMed     Text format     Abstract available


  5. RIBEIRO L, Gomes M, Gaio R, Duarte R, et al
    HIV screening of tuberculosis patients in Portugal: what are we missing?
    Int J Tuberc Lung Dis. 2018;22:1216-1219.
    PubMed     Text format     Abstract available


  6. MEKONNEN A, Collins JM, Aseffa A, Ameni G, et al
    Prevalence of pulmonary tuberculosis among students in three eastern Ethiopian universities.
    Int J Tuberc Lung Dis. 2018;22:1210-1215.
    PubMed     Text format     Abstract available


  7. MORASERT T, Worapas W, Kaewmahit R, Uphala W, et al
    Prevalence and risk factors associated with tuberculosis disease in Suratthani Central Prison, Thailand.
    Int J Tuberc Lung Dis. 2018;22:1203-1209.
    PubMed     Text format     Abstract available


  8. KIZITO S, Katamba A, Marquez C, Turimumahoro P, et al
    Quality of care in childhood tuberculosis diagnosis at primary care clinics in Kampala, Uganda.
    Int J Tuberc Lung Dis. 2018;22:1196-1202.
    PubMed     Text format     Abstract available


  9. BELGAUMKAR V, Chandanwale A, Valvi C, Pardeshi G, et al
    Barriers to screening and isoniazid preventive therapy for child contacts of tuberculosis patients.
    Int J Tuberc Lung Dis. 2018;22:1179-1187.
    PubMed     Text format     Abstract available


  10. SILVEIRA MBV, Ferrarini MAG, Viana PO, Succi RC, et al
    Contribution of the interferon-gamma release assay to tuberculosis diagnosis in children and adolescents.
    Int J Tuberc Lung Dis. 2018;22:1172-1178.
    PubMed     Text format     Abstract available


  11. PELISSARI DM, Kuhleis DC, Bartholomay P, Barreira D, et al
    Prevalence and screening of active tuberculosis in a prison in the South of Brazil.
    Int J Tuberc Lung Dis. 2018;22:1166-1171.
    PubMed     Text format     Abstract available


  12. ARMSTRONG-HOUGH M, Ggita J, Turimumahoro P, Meyer AJ, et al
    'Something so hard': a mixed-methods study of home sputum collection for tuberculosis contact investigation in Uganda.
    Int J Tuberc Lung Dis. 2018;22:1152-1159.
    PubMed     Text format     Abstract available


  13. KHAING PS, Kyaw NTT, Satyanarayana S, Oo NL, et al
    Treatment outcome of tuberculosis patients detected using accelerated vs. passive case finding in Myanmar.
    Int J Tuberc Lung Dis. 2018;22:1145-1151.
    PubMed     Text format     Abstract available


  14. HAMILTON K, Tolfree R, Mytton J
    A systematic review of active case-finding strategies for tuberculosis in homeless populations.
    Int J Tuberc Lung Dis. 2018;22:1135-1144.
    PubMed     Text format     Abstract available


  15. COHEN DB, Meghji J, Squire SB
    A systematic review of clinical outcomes on the WHO Category II retreatment regimen for tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:1127-1134.
    PubMed     Text format     Abstract available


  16. HARRIES AD, Lin Y, Kumar AMV, Satyanarayana S, et al
    How can integrated care and research assist in achieving the SDG targets for diabetes, tuberculosis and HIV/AIDS?
    Int J Tuberc Lung Dis. 2018;22:1117-1126.
    PubMed     Text format     Abstract available


  17. PARK J, Yim JJ
    Diagnosis of tuberculosis among children: leave no stone unturned.
    Int J Tuberc Lung Dis. 2018;22:1116.
    PubMed     Text format    


  18. AULD SC, Gandhi NR, Shah NS
    Closing the book on Category II: time for individualized regimens for patients with recurrent tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:1113-1114.
    PubMed     Text format    


  19. BAO J, Hafner R, Lin Y, Lin HH, et al
    Curbing the tuberculosis and diabetes co-epidemic: strategies for the integration of clinical care and research.
    Int J Tuberc Lung Dis. 2018;22:1111-1112.
    PubMed     Text format    


    September 2018
  20. FOSTER J, McBryde E, Taune M, Peniyamina D, et al
    Cross-border tuberculosis: opportunities, challenges and change.
    Int J Tuberc Lung Dis. 2018;22:1107-1108.
    PubMed     Text format    


  21. BARRETO JN, de Lourdes Monteiro M, da Luz Lima M, Valadas E, et al
    Under-reporting of tuberculosis in Praia, Cape Verde: study reports doubtful results.
    Int J Tuberc Lung Dis. 2018;22:1106.
    PubMed     Text format    


  22. KOESOEMADINATA RC, Kranzer K, Livia R, Susilawati N, et al
    Computer-assisted chest radiography reading for tuberculosis screening in people living with diabetes mellitus.
    Int J Tuberc Lung Dis. 2018;22:1088-1094.
    PubMed     Text format     Abstract available


  23. RAGHUVANSHI S, Kotwal A, Maheshwari R, Sindhwani G, et al
    Evaluation of line-probe assay for molecular analysis and drug susceptibility of extra-pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:1077-1081.
    PubMed     Text format     Abstract available


  24. GASPAR PC, Rudolf-Oliveira RCM, Wildner LM, de Moraes ACR, et al
    Evaluation of leucocytes from sputum samples of pulmonary tuberculosis patients using flow cytometry.
    Int J Tuberc Lung Dis. 2018;22:1071-1076.
    PubMed     Text format     Abstract available


  25. TAKENAMI I, de Oliveira CC, Petrilli JD, Machado A, et al
    Serum antiphospholipid antibody levels as biomarkers for diagnosis of pulmonary tuberculosis patients.
    Int J Tuberc Lung Dis. 2018;22:1063-1070.
    PubMed     Text format     Abstract available


  26. MYO K, Zaw M, Swe TL, Kyaw YY, et al
    Evaluation of Xpert((R)) MTB/RIF assay as a diagnostic test for pulmonary tuberculosis in children in Myanmar.
    Int J Tuberc Lung Dis. 2018;22:1051-1055.
    PubMed     Text format     Abstract available


  27. HO-FOSTER A, Tenforde MW, Arscott-Mills T, Maramba M, et al
    Risk factors for gastric aspirate culture contamination in children evaluated for tuberculosis in Botswana.
    Int J Tuberc Lung Dis. 2018;22:1044-1050.
    PubMed     Text format     Abstract available


  28. DU PREEZ K, du Plessis L, O'Connell N, Hesseling AC, et al
    Burden, spectrum and outcomes of children with tuberculosis diagnosed at a district-level hospital in South Africa.
    Int J Tuberc Lung Dis. 2018;22:1037-1043.
    PubMed     Text format     Abstract available


  29. OH CE, Kwon GY, Kwon YH, Lee EJ, et al
    High tuberculosis transmission rate in children with nursery exposure to undetected pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:1031-1036.
    PubMed     Text format     Abstract available


  30. SWINDELLS S, Gupta A, Kim S, Hughes MD, et al
    Resource utilization for multidrug-resistant tuberculosis household contact investigations (A5300/I2003).
    Int J Tuberc Lung Dis. 2018;22:1016-1022.
    PubMed     Text format     Abstract available


  31. MONK EJM, Kumwenda M, Nliwasa M, Mpunga J, et al
    Factors affecting tuberculosis health message recall 2 years after active case finding in Blantyre, Malawi.
    Int J Tuberc Lung Dis. 2018;22:1007-1015.
    PubMed     Text format     Abstract available


  32. ZUUR MA, van Asselt ADI, van 't Boveneind-Vrubleuskaya N, Aleksa A, et al
    Cost-utility analysis of high-dose treatment for intermediate-susceptible, dose-dependent tuberculosis patients.
    Int J Tuberc Lung Dis. 2018;22:991-999.
    PubMed     Text format     Abstract available


  33. NHUNG NV, Hoa NB, Anh NT, Anh LTN, et al
    Measuring catastrophic costs due to tuberculosis in Viet Nam.
    Int J Tuberc Lung Dis. 2018;22:983-990.
    PubMed     Text format     Abstract available


  34. DONALD PR, Diacon AH, Lange C, Demers AM, et al
    Droplets, dust and guinea pigs: an historical review of tuberculosis transmission research, 1878-1940.
    Int J Tuberc Lung Dis. 2018;22:972-982.
    PubMed     Text format     Abstract available


  35. SCHWARTZMAN K
    You pay for what you get: the true cost of tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:969.
    PubMed     Text format    


    August 2018
  36. CHAN ED
    Thin body habitus is a risk factor for active pulmonary tuberculosis, but not for infection.
    Int J Tuberc Lung Dis. 2018;22:967-968.
    PubMed     Text format    


  37. ZELLWEGER JP
    Multidrug-resistant tuberculosis in Ukraine: what is hidden behind the numbers?
    Int J Tuberc Lung Dis. 2018;22:966-967.
    PubMed     Text format    


  38. YAN ZH, Yi L, Wei PJ, Jia HY, et al
    Evaluation of panels of Mycobacterium tuberculosis antigens for serodiagnosis of tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:959-965.
    PubMed     Text format     Abstract available


  39. DUPNIK KM, Bean JM, Lee MH, Jean Juste MA, et al
    Blood transcriptomic markers of Mycobacterium tuberculosis load in sputum.
    Int J Tuberc Lung Dis. 2018;22:950-958.
    PubMed     Text format     Abstract available


  40. RAJOLI RKR, Podany AT, Moss DM, Swindells S, et al
    Modelling the long-acting administration of anti-tuberculosis agents using PBPK: a proof of concept study.
    Int J Tuberc Lung Dis. 2018;22:937-944.
    PubMed     Text format     Abstract available


  41. ZHU H, Guo SC, Liu ZQ, Wang B, et al
    Therapeutic drug monitoring of cycloserine and linezolid during anti-tuberculosis treatment in Beijing, China.
    Int J Tuberc Lung Dis. 2018;22:931-936.
    PubMed     Text format     Abstract available


  42. COURT RG, Wiesner L, Chirehwa MT, Stewart A, et al
    Effect of lidocaine on kanamycin injection-site pain in patients with multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:926-930.
    PubMed     Text format     Abstract available


  43. SCHNIPPEL K, Firnhaber C, Page-Shipp L, Sinanovic E, et al
    Impact of adverse drug reactions on the incremental cost-effectiveness of bedaquiline for drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:918-925.
    PubMed     Text format     Abstract available


  44. NAM VX, Nhung NV, Hoa NB, Thuy HTT, et al
    Economic burden of multidrug-resistant tuberculosis: a multicenter study across Vietnamese regions.
    Int J Tuberc Lung Dis. 2018;22:912-917.
    PubMed     Text format     Abstract available


  45. COLLINS D, Beyene D, Tedla Y, Mesfin H, et al
    Can patients afford the cost of treatment for multidrug-resistant tuberculosis in Ethiopia?
    Int J Tuberc Lung Dis. 2018;22:905-911.
    PubMed     Text format     Abstract available


  46. DUNBAR R, Naidoo P, Beyers N, Langley I, et al
    Improving rifampicin-resistant tuberculosis diagnosis using Xpert((R)) MTB/RIF: modelling interventions and costs.
    Int J Tuberc Lung Dis. 2018;22:890-898.
    PubMed     Text format     Abstract available


  47. CHAUDHARY A, Singh JP, Sehajpal PK, Sarin BC, et al
    P2X7 receptor polymorphisms and susceptibility to tuberculosis in a North Indian Punjabi population.
    Int J Tuberc Lung Dis. 2018;22:884-889.
    PubMed     Text format     Abstract available


  48. CHAWLA K, Kumar A, Shenoy VP, Chauhan DS, et al
    Strain diversity and relative transmission of Mycobacterium tuberculosis in south coastal Karnataka, India.
    Int J Tuberc Lung Dis. 2018;22:878-883.
    PubMed     Text format     Abstract available


  49. VAN DER HEIJDEN YF, Karim F, Chinappa T, Mufamadi G, et al
    Older age at first tuberculosis diagnosis is associated with tuberculosis recurrence in HIV-negative persons.
    Int J Tuberc Lung Dis. 2018;22:871-877.
    PubMed     Text format     Abstract available


  50. TURNER RD, Birring SS, Darmalingam M, Hooper RL, et al
    Daily cough frequency in tuberculosis and association with household infection.
    Int J Tuberc Lung Dis. 2018;22:863-870.
    PubMed     Text format     Abstract available


  51. HIRSCH-MOVERMAN Y, Mantell JE, Lebelo L, Wynn C, et al
    Tuberculosis preventive treatment preferences among care givers of children in Lesotho: a pilot study.
    Int J Tuberc Lung Dis. 2018;22:858-862.
    PubMed     Text format     Abstract available


  52. MALIK AA, Amanullah F, Codlin AJ, Siddiqui S, et al
    Improving childhood tuberculosis detection and treatment through facility-based screening in rural Pakistan.
    Int J Tuberc Lung Dis. 2018;22:851-857.
    PubMed     Text format     Abstract available


  53. SHETE PB, Boccia D, Dhavan P, Gebreselassie N, et al
    Defining a migrant-inclusive tuberculosis research agenda to end TB.
    Int J Tuberc Lung Dis. 2018;22:835-843.
    PubMed     Text format     Abstract available


  54. DOOLEY KE
    Long-acting injectables for tuberculosis prophylaxis and treatment: is now the time?
    Int J Tuberc Lung Dis. 2018;22:833-834.
    PubMed     Text format    


  55. CAMINERO JA, Scardigli A
    The economic burden of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:831-832.
    PubMed     Text format    


  56. SOMOSKOVI A, Gutierrez C
    Gaps in understanding factors influencing tuberculosis recurrence.
    Int J Tuberc Lung Dis. 2018;22:830.
    PubMed     Text format    


    July 2018
  57. HYDER MKA, Tripathy JP, Kaur J, Mandal PP, et al
    Tuberculosis-tobacco integration in the South-East Asia Region: policy analysis and implementation framework.
    Int J Tuberc Lung Dis. 2018;22:807-812.
    PubMed     Text format     Abstract available


  58. SINHA P, Moll AP, Brooks RP, Deng YH, et al
    Synergism between diabetes and human immunodeficiency virus in increasing the risk of tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:793-799.
    PubMed     Text format     Abstract available


  59. SCHININA V, Albarello F, Cristofaro M, Di Stefano F, et al
    Diagnostic imaging of hepatic tuberculosis: case series.
    Int J Tuberc Lung Dis. 2018;22:779-787.
    PubMed     Text format     Abstract available


  60. WALKER IF, Khan AM, Khan AM, Khan NM, et al
    Depression among multidrug-resistant tuberculosis patients in Punjab, Pakistan: a large cross-sectional study.
    Int J Tuberc Lung Dis. 2018;22:773-778.
    PubMed     Text format     Abstract available


  61. ODAYAR J, Rangaka MX, Zerbe A, Petro G, et al
    Burden of tuberculosis in HIV-positive pregnant women in Cape Town, South Africa.
    Int J Tuberc Lung Dis. 2018;22:760-765.
    PubMed     Text format     Abstract available


  62. GIMENEZ-DURAN J, Galmes-Truyols A, Gonzalez-Cortijo T, Portell-Arbona M, et al
    Capture-recapture and anti-tuberculosis drug prescriptions, Balearic Islands, Spain, 2010-2012.
    Int J Tuberc Lung Dis. 2018;22:754-759.
    PubMed     Text format     Abstract available


  63. REEVE BWP, McFall SM, Song R, Warren R, et al
    Commercial products to preserve specimens for tuberculosis diagnosis: a systematic review.
    Int J Tuberc Lung Dis. 2018;22:741-753.
    PubMed     Text format     Abstract available


  64. MULLER AM, Osorio CS, Silva DR, Sbruzzi G, et al
    Interventions to improve adherence to tuberculosis treatment: systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2018;22:731-740.
    PubMed     Text format     Abstract available


  65. FLOYD K, Glaziou P, Houben RMGJ, Sumner T, et al
    Global tuberculosis targets and milestones set for 2016-2035: definition and rationale.
    Int J Tuberc Lung Dis. 2018;22:723-730.
    PubMed     Text format     Abstract available


  66. WINTER JR, Adamu AL, Gupta RK, Stagg HR, et al
    Tuberculosis infection and disease in people living with HIV in countries with low tuberculosis incidence.
    Int J Tuberc Lung Dis. 2018;22:713-722.
    PubMed     Text format     Abstract available


  67. CASTRO KG, Colvin CE
    Updated global tuberculosis targets: a welcome ambition in need of attention to quality of care.
    Int J Tuberc Lung Dis. 2018;22:709.
    PubMed     Text format    


  68. GUPTE AN, Mave V, Meshram S, Lokhande R, et al
    Trends in HbA1c levels and implications for diabetes screening in tuberculosis cases undergoing treatment in India.
    Int J Tuberc Lung Dis. 2018;22:800-806.
    PubMed     Text format     Abstract available


    June 2018
  69. YABLONSKII PK, Avetisyan AO, Vasilev IV, Kudriashov GG, et al
    Robot-assisted lobectomy for pulmonary tuberculosis in a case with immunosuppression after kidney transplantation.
    Int J Tuberc Lung Dis. 2018;22:704-705.
    PubMed     Text format    


  70. SHIVAKUMAR SVBY, Chandrasekaran P, Kumar AMV, Paradkar M, et al
    Diabetes and pre-diabetes among household contacts of tuberculosis patients in India: is it time to screen them all?
    Int J Tuberc Lung Dis. 2018;22:686-694.
    PubMed     Text format     Abstract available


  71. CHIEN K, Seemangal J, Batt J, Vozoris NT, et al
    Abdominal tuberculosis: a descriptive case series of the experience in a Canadian tuberculosis clinic.
    Int J Tuberc Lung Dis. 2018;22:681-685.
    PubMed     Text format     Abstract available


  72. JACOBS MG, Pelissari DM, Pinto VL
    Factors associated with the drug-resistant tuberculosis incidence rate in Brazil.
    Int J Tuberc Lung Dis. 2018;22:675-680.
    PubMed     Text format     Abstract available


  73. LIU Y, Zheng Y, Chen J, Shi Y, et al
    Tuberculosis-associated mortality and its risk factors in a district of Shanghai, China: a retrospective cohort study.
    Int J Tuberc Lung Dis. 2018;22:655-660.
    PubMed     Text format     Abstract available


  74. MANSOUR O, Masini EO, Kim BJ, Kamene M, et al
    Impact of a national nutritional support programme on loss to follow-up after tuberculosis diagnosis in Kenya.
    Int J Tuberc Lung Dis. 2018;22:649-654.
    PubMed     Text format     Abstract available


  75. BOURGEOIS AC, Zulz T, Bruce MG, Stenz F, et al
    Tuberculosis in the Circumpolar Region, 2006-2012.
    Int J Tuberc Lung Dis. 2018;22:641-648.
    PubMed     Text format     Abstract available


  76. WANG KY, Lin YS, Sy CL, Huang WC, et al
    Hyperbaric oxygen therapy increases the risk of tuberculosis disease.
    Int J Tuberc Lung Dis. 2018;22:637-640.
    PubMed     Text format     Abstract available


  77. YANG ZH, Gorden T, Liu DP, Mukasa L, et al
    Increasing likelihood of advanced pulmonary tuberculosis at initial diagnosis in a low-incidence US state.
    Int J Tuberc Lung Dis. 2018;22:628-636.
    PubMed     Text format     Abstract available


  78. POPE V, Sacksteder KA, Hererra JC, Gilman RH, et al
    MPT64 patch test for the diagnosis of active pulmonary tuberculosis: a randomised controlled trial in Peru.
    Int J Tuberc Lung Dis. 2018;22:622-627.
    PubMed     Text format     Abstract available


  79. HORNE DJ, Jones BE, Kamada A, Fukushima K, et al
    Multicenter study of QuantiFERON((R))-TB Gold Plus in patients with active tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:617-621.
    PubMed     Text format     Abstract available


  80. WHITE RG, Charalambous S, Cardenas V, Hippner P, et al
    Evidence-informed policy making at country level: lessons learned from the South African Tuberculosis Think Tank.
    Int J Tuberc Lung Dis. 2018;22:606-613.
    PubMed     Text format     Abstract available


  81. DARA M, Zachariah R
    Hunger and tuberculosis: two sides of the same coin.
    Int J Tuberc Lung Dis. 2018;22:592.
    PubMed     Text format    


    May 2018
  82. KIM S, Seddon JA, Garcia-Prats AJ, Montepiedra G, et al
    Statistical considerations for pediatric multidrug-resistant tuberculosis efficacy trials.
    Int J Tuberc Lung Dis. 2018;22:34-39.
    PubMed     Text format     Abstract available


  83. GARCIA-PRATS AJ, Svensson EM, Weld ED, Schaaf HS, et al
    Current status of pharmacokinetic and safety studies of multidrug-resistant tuberculosis treatment in children.
    Int J Tuberc Lung Dis. 2018;22:15-23.
    PubMed     Text format     Abstract available


  84. TUCKER EW, Dooley KE
    Preclinical tools for the evaluation of tuberculosis treatment regimens for children.
    Int J Tuberc Lung Dis. 2018;22:7-14.
    PubMed     Text format     Abstract available


  85. JENKINS HE, Yuen CM
    The burden of multidrug-resistant tuberculosis in children.
    Int J Tuberc Lung Dis. 2018;22:3-6.
    PubMed     Text format     Abstract available


  86. LALOR MK, Mohiyuddin T, Uddin T, Thomas HL, et al
    The challenge of estimating tuberculosis mortality accurately in England and Wales.
    Int J Tuberc Lung Dis. 2018;22:572-578.
    PubMed     Text format     Abstract available


  87. MELENDEZ J, Hogeweg L, Sanchez CI, Philipsen RHHM, et al
    Accuracy of an automated system for tuberculosis detection on chest radiographs in high-risk screening.
    Int J Tuberc Lung Dis. 2018;22:567-571.
    PubMed     Text format     Abstract available


  88. KUHLIN J, Smith C, Khaemraev A, Tigay Z, et al
    Impact of pyrazinamide resistance on multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan.
    Int J Tuberc Lung Dis. 2018;22:544-550.
    PubMed     Text format     Abstract available


  89. GGITA JM, Ojok C, Meyer AJ, Farr K, et al
    Patterns of usage and preferences of users for tuberculosis-related text messages and voice calls in Uganda.
    Int J Tuberc Lung Dis. 2018;22:530-536.
    PubMed     Text format     Abstract available


  90. MERID Y, Woldeamanuel Y, Abebe M, Datiko DG, et al
    High utility of active tuberculosis case finding in an Ethiopian prison.
    Int J Tuberc Lung Dis. 2018;22:524-529.
    PubMed     Text format     Abstract available


  91. KAWATSU L, Uchimura K, Izumi K, Ohkado A, et al
    Using surveillance data to simulate the impact of a hypothetical pre-entry tuberculosis screening programme in Japan.
    Int J Tuberc Lung Dis. 2018;22:510-517.
    PubMed     Text format     Abstract available


  92. SOHN H, Kim HY, Lee SH
    Cost-effectiveness of contact screening strategies for tuberculosis among high-school adolescents in South Korea.
    Int J Tuberc Lung Dis. 2018;22:496-503.
    PubMed     Text format     Abstract available


  93. BYAMUNGU LN, du Preez K, Walters E, Nachega JB, et al
    Timing of HIV diagnosis in children with tuberculosis managed at a referral hospital in Cape Town, South Africa.
    Int J Tuberc Lung Dis. 2018;22:488-495.
    PubMed     Text format     Abstract available


  94. GUPTA RK, Lipman M, Story A, Hayward A, et al
    Active case finding and treatment adherence in risk groups in the tuberculosis pre-elimination era.
    Int J Tuberc Lung Dis. 2018;22:479-487.
    PubMed     Text format     Abstract available


  95. VELASQUEZ GE, Davies GR, Mitnick CD
    Making up the difference: ensuring the bioequivalence of fixed-dose combinations for tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:473-474.
    PubMed     Text format    


    April 2018
  96. HARRIES AD
    Impact of antiretroviral therapy on tuberculosis control.
    Int J Tuberc Lung Dis. 2018;22:466-467.
    PubMed     Text format    


  97. PAYEN MC, De Wit S
    In Reply: Synergy between amoxicillin and meropenem/clavulanate in drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:465-466.
    PubMed     Text format    


  98. MISHRA GP, Caminero JA
    Low-dose amoxicillin-clavulanate in drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:465.
    PubMed     Text format    


  99. CLICK ES, Ouma GS, DeGruy K, Murithi W, et al
    No evidence of Mycobacterium tuberculosis in breast milk of 18 women with confirmed TB disease in Kisumu, Kenya.
    Int J Tuberc Lung Dis. 2018;22:464-465.
    PubMed     Text format    


  100. MATHYS V, Roycroft E, Raftery P, Groenheit R, et al
    Time-and-motion tool for the assessment of working time in tuberculosis laboratories: a multicentre study.
    Int J Tuberc Lung Dis. 2018;22:444-451.
    PubMed     Text format     Abstract available


  101. BASHAM CA, Elias B, Fanning A, Cook C, et al
    Performance measurement of a Canadian provincial tuberculosis programme: Manitoba, 2008-2012.
    Int J Tuberc Lung Dis. 2018;22:437-443.
    PubMed     Text format     Abstract available


  102. MASKERY B, Posey DL, Coleman MS, Asis R, et al
    Economic analysis of CDC's culture- and smear-based tuberculosis instructions for Filipino immigrants.
    Int J Tuberc Lung Dis. 2018;22:429-436.
    PubMed     Text format     Abstract available


  103. ADEPOYIBI T, Lilis L, Greb H, Boyle D, et al
    Which attributes within target product profiles for tuberculosis diagnostics are the most important to focus on?
    Int J Tuberc Lung Dis. 2018;22:425-428.
    PubMed     Text format     Abstract available


  104. YADAV R, Saini A, Kaur P, Behera D, et al
    Diagnostic accuracy of GenoType((R)) MTBDRsl VER 2.0 in detecting second-line drug resistance to M. tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:419-424.
    PubMed     Text format     Abstract available


  105. COX V, Brigden G, Crespo RH, Lessem E, et al
    Global programmatic use of bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:407-412.
    PubMed     Text format     Abstract available


  106. HEYCKENDORF J, van Leth F, Avsar K, Glattki G, et al
    Treatment responses in multidrug-resistant tuberculosis in Germany.
    Int J Tuberc Lung Dis. 2018;22:399-406.
    PubMed     Text format     Abstract available


  107. SCHNIPPEL K, Firnhaber C, Berhanu R, Page-Shipp L, et al
    Direct costs of managing adverse drug reactions during rifampicin-resistant tuberculosis treatment in South Africa.
    Int J Tuberc Lung Dis. 2018;22:393-398.
    PubMed     Text format     Abstract available


  108. HTET KKK, Soe KT, Kumar AMV, Saw S, et al
    Rifampicin-resistant tuberculosis patients in Myanmar in 2016: how many are lost on the path to treatment?
    Int J Tuberc Lung Dis. 2018;22:385-392.
    PubMed     Text format     Abstract available


  109. ONYOH EF, Kuaban C, Lin HH
    Pre-treatment loss to follow-up of pulmonary tuberculosis patients in two regions of Cameroon.
    Int J Tuberc Lung Dis. 2018;22:378-384.
    PubMed     Text format     Abstract available


  110. SHIN SS, Modongo C, Zetola NM, Wang Q, et al
    High rates of exposure to tuberculosis patients among HIV-infected health care workers in Botswana.
    Int J Tuberc Lung Dis. 2018;22:366-370.
    PubMed     Text format     Abstract available


    March 2018
  111. JACOBS C, Goussard P, Gie RP
    Mycobacterium tuberculosis, a cause of necrotising pneumonia in childhood: a case series.
    Int J Tuberc Lung Dis. 2018 Mar 22. doi: 10.5588/ijtld.17.0570.
    PubMed     Text format     Abstract available


  112. NAMIIRO S, Wobudeya E, Colebunders R, Worodria W, et al
    Molecular tests expedite the diagnosis of multidrug-resistant tuberculosis in childhood.
    Int J Tuberc Lung Dis. 2018;22:349-350.
    PubMed     Text format    


  113. BRUMWELL A, Noyes E, Kulkarni S, Lin V, et al
    A rapid review of treatment literacy materials for tuberculosis patients.
    Int J Tuberc Lung Dis. 2018;22:336-341.
    PubMed     Text format     Abstract available


  114. BECKER AS, Bluthgen C, Phi van VD, Sekaggya-Wiltshire C, et al
    Detection of tuberculosis patterns in digital photographs of chest X-ray images using Deep Learning: feasibility study.
    Int J Tuberc Lung Dis. 2018;22:328-335.
    PubMed     Text format     Abstract available


  115. D'ATTILIO L, Diaz A, Fernandez RDV, Bongiovanni B, et al
    The neuro-endocrine-immune relationship in pulmonary and pleural tuberculosis: a better local profile in pleural fluid.
    Int J Tuberc Lung Dis. 2018;22:321-327.
    PubMed     Text format     Abstract available


  116. OLARU ID, Albert H, Zallet J, Werner UE, et al
    Impact of quality improvement in tuberculosis laboratories in low- and lower-middle-income countries: a systematic review.
    Int J Tuberc Lung Dis. 2018;22:309-320.
    PubMed     Text format     Abstract available


  117. BARK CM, Thiel BA, Ogwang S, Sekitoleko I, et al
    Sputum smear-positive, culture-negative state during anti-tuberculosis treatment in the MGIT liquid culture era.
    Int J Tuberc Lung Dis. 2018;22:306-308.
    PubMed     Text format     Abstract available


  118. FAN YM, Ding SP, Bao ZJ, Wu LM, et al
    Prognostic factors for treatment success in patients with multidrug-resistant tuberculosis in China.
    Int J Tuberc Lung Dis. 2018;22:300-305.
    PubMed     Text format     Abstract available


  119. FRANCIS JR, Manchikanti P, Blyth CC, Denholm J, et al
    Multidrug-resistant tuberculosis in Australia, 1998-2012.
    Int J Tuberc Lung Dis. 2018;22:294-299.
    PubMed     Text format     Abstract available


  120. SMITH CM, Lessells R, Grant AD, Herbst K, et al
    Spatial clustering of drug-resistant tuberculosis in Hlabisa subdistrict, KwaZulu-Natal, 2011-2015.
    Int J Tuberc Lung Dis. 2018;22:287-293.
    PubMed     Text format     Abstract available


  121. NGWIRA LG, Dowdy DW, Khundi M, Barnes GL, et al
    Delay in seeking care for tuberculosis symptoms among adults newly diagnosed with HIV in rural Malawi.
    Int J Tuberc Lung Dis. 2018;22:280-286.
    PubMed     Text format     Abstract available


  122. KWEZA PF, Van Schalkwyk C, Abraham N, Uys M, et al
    Estimating the magnitude of pulmonary tuberculosis patients missed by primary health care clinics in South Africa.
    Int J Tuberc Lung Dis. 2018;22:264-272.
    PubMed     Text format     Abstract available


  123. FURTADO DA LUZ E, Braga JU
    Under-reporting of tuberculosis in Praia, Cape Verde, from 2006 to 2012.
    Int J Tuberc Lung Dis. 2018;22:258-263.
    PubMed     Text format     Abstract available


  124. DAVIDSON JA, Fulton N, Thomas HL, Lalor MK, et al
    Investigating a tuberculosis cluster among Filipino health care workers in a low-incidence country.
    Int J Tuberc Lung Dis. 2018;22:252-257.
    PubMed     Text format     Abstract available


  125. VAN DEUN A, Decroo T, Piubello A, de Jong BC, et al
    Principles for constructing a tuberculosis treatment regimen: the role and definition of core and companion drugs.
    Int J Tuberc Lung Dis. 2018;22:239-245.
    PubMed     Text format     Abstract available


    February 2018
  126. ALSHEVSKAYA AA, Kireev FD, Laushkina ZA, Lopatnikova JA, et al
    Enhanced expression of TNF-alpha type-1 receptors by immune cells in active pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:212-220.
    PubMed     Text format     Abstract available


  127. BAIRD T, Donnan E, Coulter C, Simpson G, et al
    Multidrug-resistant tuberculosis in Queensland, Australia: an ongoing cross-border challenge.
    Int J Tuberc Lung Dis. 2018;22:206-211.
    PubMed     Text format     Abstract available


  128. PAVLENKO E, Barbova A, Hovhannesyan A, Tsenilova Z, et al
    Alarming levels of multidrug-resistant tuberculosis in Ukraine: results from the first national survey.
    Int J Tuberc Lung Dis. 2018;22:197-205.
    PubMed     Text format     Abstract available


  129. ANTHONY-WILLIAMS MH, Farrugia BB, Montefort S
    Tuberculosis notification and treatment outcome among migrant boat arrivals in Malta, 2007-2011.
    Int J Tuberc Lung Dis. 2018;22:194-196.
    PubMed     Text format     Abstract available


  130. TAHSEEN S, Shahnawaz H, Riaz U, Khanzada FM, et al
    Systematic case finding for tuberculosis in HIV-infected people who inject drugs: experience from Pakistan.
    Int J Tuberc Lung Dis. 2018;22:187-193.
    PubMed     Text format     Abstract available


  131. JIAMSAKUL A, Lee MP, Nguyen KV, Merati TP, et al
    Socio-economic status and risk of tuberculosis: a case-control study of HIV-infected patients in Asia.
    Int J Tuberc Lung Dis. 2018;22:179-186.
    PubMed     Text format     Abstract available


  132. DE CASTRO DB, Sadahiro M, Pinto RC, de Albuquerque BC, et al
    Spatial distribution of tuberculosis in Manaus and its social determinants, 2008-2013.
    Int J Tuberc Lung Dis. 2018;22:171-178.
    PubMed     Text format     Abstract available


  133. ROSSER A, Marx FM, Pareek M
    Recurrent tuberculosis in the pre-elimination era.
    Int J Tuberc Lung Dis. 2018;22:139-150.
    PubMed     Text format     Abstract available


  134. ODONE A, Roberts B, Dara M, van den Boom M, et al
    People- and patient-centred care for tuberculosis: models of care for tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:133-138.
    PubMed     Text format     Abstract available


    January 2018
  135. BYRNE AL, Marais BJ, Mitnick CD, Garden FL, et al
    Feasibility and yield of screening for non-communicable diseases among treated tuberculosis patients in Peru.
    Int J Tuberc Lung Dis. 2018;22:86-92.
    PubMed     Text format     Abstract available


  136. PINTO PFPS, Neto FC, de Almeida Ribeiro MCS
    Tuberculosis among South American immigrants in Sao Paulo municipality: an analysis in space and time.
    Int J Tuberc Lung Dis. 2018;22:80-85.
    PubMed     Text format     Abstract available


  137. WONG J, Lowenthal P, Flood J, Watt J, et al
    Increased tuberculosis risk among immigrants arriving in California with abnormal domestic chest radiographs.
    Int J Tuberc Lung Dis. 2018;22:73-79.
    PubMed     Text format     Abstract available


  138. SHIMAZAKI T, Taniguchi T, Saludar NRD, Gustilo LM, et al
    Bacterial co-infection and early mortality among pulmonary tuberculosis patients in Manila, The Philippines.
    Int J Tuberc Lung Dis. 2018;22:65-72.
    PubMed     Text format     Abstract available


  139. LEE B, Oh HJ, Chon BS
    Estimating the impact of a television campaign on tuberculosis knowledge and intention to test for TB in South Korea.
    Int J Tuberc Lung Dis. 2018;22:60-64.
    PubMed     Text format     Abstract available


  140. GUGLIELMETTI L, Veziris N, Aubry A, Brossier F, et al
    Risk factors for extensive drug resistance in multidrug-resistant tuberculosis cases: a case-case study.
    Int J Tuberc Lung Dis. 2018;22:54-59.
    PubMed     Text format     Abstract available


  141. EI PW, Aung WW, Nyunt WW, Swe TL, et al
    Extensively drug-resistant tuberculosis in Myanmar: burden and mutations causing second-line drug resistance.
    Int J Tuberc Lung Dis. 2018;22:47-53.
    PubMed     Text format     Abstract available


  142. LOVEDAY M, Sunkari B, Master I, Daftary A, et al
    Household context and psychosocial impact of childhood multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa.
    Int J Tuberc Lung Dis. 2018;22:40-46.
    PubMed     Text format     Abstract available


  143. PAYEN MC, Muylle I, Vandenberg O, Mathys V, et al
    Meropenem-clavulanate for drug-resistant tuberculosis: a follow-up of relapse-free cases.
    Int J Tuberc Lung Dis. 2018;22:34-39.
    PubMed     Text format     Abstract available


  144. COURT R, Wiesner L, Stewart A, de Vries N, et al
    Steady state pharmacokinetics of cycloserine in patients on terizidone for multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:30-33.
    PubMed     Text format     Abstract available


  145. LEE PH, Fu H, Lee MR, Magee M, et al
    Tuberculosis and diabetes in low and moderate tuberculosis incidence countries.
    Int J Tuberc Lung Dis. 2018;22:7-16.
    PubMed     Text format     Abstract available


  146. JACKSON C, Cohen T, Rangaka MX, Abubakar I, et al
    Eliminating tuberculosis in low-burden countries.
    Int J Tuberc Lung Dis. 2018;22:3.
    PubMed     Text format    


  147. ALFFENAAR JWC, Peloquin CA, Migliori GB
    Making optimal use of available anti-tuberculosis drugs: first steps to investigate terizidone.
    Int J Tuberc Lung Dis. 2018;22:2.
    PubMed     Text format    


    December 2017
  148. NANSUMBA M, Kumbakumba E, Orikiriza P, Bastard M, et al
    Treatment outcomes and tolerability of the revised WHO anti-tuberculosis drug dosages for children.
    Int J Tuberc Lung Dis. 2017 Dec 20. doi: 10.5588/ijtld.17.0535.
    PubMed     Text format     Abstract available


  149. ALLWOOD BW, van Zyl-Smit R
    Tuberculosis, chronic obstructive pulmonary disease and inhaled corticosteroids: a complex web.
    Int J Tuberc Lung Dis. 2017;21:1317-1318.
    PubMed     Text format    


  150. ZELLWEGER JP
    Depression and risk of tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:1314.
    PubMed     Text format    


  151. YU ZG, Wang BZ, Li J, Ding ZL, et al
    Association between interleukin-17 genetic polymorphisms and tuberculosis susceptibility: an updated meta-analysis.
    Int J Tuberc Lung Dis. 2017;21:1307-1313.
    PubMed     Text format     Abstract available


  152. SHU E, Sobieszczyk ME, Sal Y Rosas VG, Segura P, et al
    Knowledge of tuberculosis and vaccine trial preparedness in Lima, Peru.
    Int J Tuberc Lung Dis. 2017;21:1288-1293.
    PubMed     Text format     Abstract available


  153. MAVE V, Meshram S, Lokhande R, Kadam D, et al
    Prevalence of dysglycemia and clinical presentation of pulmonary tuberculosis in Western India.
    Int J Tuberc Lung Dis. 2017;21:1280-1287.
    PubMed     Text format     Abstract available


  154. DELORY T, Ferrand H, Grall N, Casalino E, et al
    Score for pulmonary tuberculosis in patients with clinical presumption of tuberculosis in a low-prevalence area.
    Int J Tuberc Lung Dis. 2017;21:1272-1279.
    PubMed     Text format     Abstract available


  155. DALE K, Tay E, Trauer JM, Trevan P, et al
    Gender differences in tuberculosis diagnosis, treatment and outcomes in Victoria, Australia, 2002-2015.
    Int J Tuberc Lung Dis. 2017;21:1264-1271.
    PubMed     Text format     Abstract available


  156. KUMWENDA M, Nyang'wa BT, Chikuse B, Biseck T, et al
    The second sputum sample complicates tuberculosis diagnosis for women: a qualitative study from Malawi.
    Int J Tuberc Lung Dis. 2017;21:1258-1263.
    PubMed     Text format     Abstract available


  157. NAGU T, Ray R, Munseri P, Moshiro C, et al
    Tuberculosis among the elderly in Tanzania: disease presentation and initial response to treatment.
    Int J Tuberc Lung Dis. 2017;21:1251-1257.
    PubMed     Text format     Abstract available


  158. MOH R, Badje A, N'takpe JB, Kouame GM, et al
    Screening for active tuberculosis before isoniazid preventive therapy among HIV-infected West African adults.
    Int J Tuberc Lung Dis. 2017;21:1237-1244.
    PubMed     Text format     Abstract available


  159. SURETTE MA, Beattie P, Nyirenda T, Olesen OF, et al
    Tackling tuberculosis in sub-Saharan Africa: EDCTP achievements and the road ahead.
    Int J Tuberc Lung Dis. 2017;21:1220-1229.
    PubMed     Text format     Abstract available


  160. HUANGFU P, Pearson F, Ugarte-Gil C, Critchley J, et al
    Diabetes and poor tuberculosis treatment outcomes: issues and implications in data interpretation and analysis.
    Int J Tuberc Lung Dis. 2017;21:1214-1219.
    PubMed     Text format     Abstract available


  161. COX V, Furin J
    World Health Organization recommendations for multidrug-resistant tuberculosis: should different standards be applied?
    Int J Tuberc Lung Dis. 2017;21:1211-1213.
    PubMed     Text format     Abstract available


    November 2017
  162. TREBUCQ A, Schwoebel V, Kashongwe Z, Bakayoko A, et al
    Treatment outcome with a short multidrug-resistant tuberculosis regimen in nine African countries.
    Int J Tuberc Lung Dis. 2017 Nov 17. doi: 10.5588/ijtld.17.0498.
    PubMed     Text format     Abstract available


  163. MAARTENS G, Brill MJE, Pandie M, Svensson EM, et al
    Pharmacokinetic interaction between bedaquiline and clofazimine in patients with drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2017 Nov 16. doi: 10.5588/ijtld.17.0615.
    PubMed     Text format     Abstract available


  164. BOYD R, Ford N, Padgen P, Cox H, et al
    Time to treatment for rifampicin-resistant tuberculosis: systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2017;21:1173-1180.
    PubMed     Text format     Abstract available


  165. MUCHENA G, Shambira G, Masuka N, Juru T, et al
    Determinants of multidrug resistance among previously treated tuberculosis patients in Zimbabwe, 2014.
    Int J Tuberc Lung Dis. 2017;21:1167-1172.
    PubMed     Text format     Abstract available


  166. GARCIA-GOEZ JF, Munera GA, Rojas V, Pacheco R, et al
    Tuberculosis in recipients of solid-organ transplants during 1995-2015 in Cali, Colombia.
    Int J Tuberc Lung Dis. 2017;21:1155-1159.
    PubMed     Text format     Abstract available


  167. KHAN PY, Crampin AC, Mzembe T, Koole O, et al
    Does antiretroviral treatment increase the infectiousness of smear-positive pulmonary tuberculosis?
    Int J Tuberc Lung Dis. 2017;21:1147-1154.
    PubMed     Text format     Abstract available


  168. RIVERA VR, Jean-Juste MA, Gluck SC, Reeder HT, et al
    Diagnostic yield of active case finding for tuberculosis and HIV at the household level in slums in Haiti.
    Int J Tuberc Lung Dis. 2017;21:1140-1146.
    PubMed     Text format     Abstract available


  169. CHEN C, Yang CG, Gao X, Lu ZZ, et al
    Community-based active case finding for tuberculosis in rural western China: a cross-sectional study.
    Int J Tuberc Lung Dis. 2017;21:1134-1139.
    PubMed     Text format     Abstract available


  170. MULDER C, Mgode GF, Ellis H, Valverde E, et al
    Accuracy of giant African pouched rats for diagnosing tuberculosis: comparison with culture and Xpert(R) MTB/RIF.
    Int J Tuberc Lung Dis. 2017;21:1127-1133.
    PubMed     Text format     Abstract available


  171. WELLS WA
    Onions and prevalence surveys: how to analyze and quantify tuberculosis case-finding gaps.
    Int J Tuberc Lung Dis. 2017;21:1101-1113.
    PubMed     Text format     Abstract available


  172. BAO J, Hafner R
    Conducting high-quality tuberculosis clinical trials in China: opportunities and challenges.
    Int J Tuberc Lung Dis. 2017;21:1094-1100.
    PubMed     Text format     Abstract available


  173. BORGDORFF MW, De Cock KM
    Provision of ART to individuals infected with HIV: impact on the epidemiology and control of tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:1091-1092.
    PubMed     Text format    


  174. MACINTYRE K, Bakker MI, Bergson S, Bhavaraju R, et al
    Defining the research agenda to measure and reduce tuberculosis stigmas.
    Int J Tuberc Lung Dis. 2017;21:87-96.
    PubMed     Text format     Abstract available


  175. SOMMERLAND N, Wouters E, Mitchell EMH, Ngicho M, et al
    Evidence-based interventions to reduce tuberculosis stigma: a systematic review.
    Int J Tuberc Lung Dis. 2017;21:81-86.
    PubMed     Text format     Abstract available


  176. SOMMERLAND N, Wouters E, Masquillier C, Engelbrecht M, et al
    Stigma as a barrier to the use of occupational health units for tuberculosis services in South Africa.
    Int J Tuberc Lung Dis. 2017;21:75-80.
    PubMed     Text format     Abstract available


  177. ZWERLING A, Dowdy D, von Delft A, Taylor H, et al
    Incorporating social justice and stigma in cost-effectiveness analysis: drug-resistant tuberculosis treatment.
    Int J Tuberc Lung Dis. 2017;21:69-74.
    PubMed     Text format     Abstract available


  178. BOND V, Floyd S, Fenty J, Schaap A, et al
    Secondary analysis of tuberculosis stigma data from a cluster randomised trial in Zambia and South Africa (ZAMSTAR).
    Int J Tuberc Lung Dis. 2017;21:49-59.
    PubMed     Text format     Abstract available


  179. MILLER C, Huston J, Samu L, Mfinanga S, et al
    'It makes the patient's spirit weaker': tuberculosis stigma and gender interaction in Dar es Salaam, Tanzania.
    Int J Tuberc Lung Dis. 2017;21:42-48.
    PubMed     Text format     Abstract available


    October 2017
  180. THAKUR C, Verma S, Negi RS, Kumar V, et al
    Lophomonas blattarum co-infection in a patient with multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:1185-1187.
    PubMed     Text format    


  181. NABIROVA D, Schmid G, Yusupova R, Kantarbayeva M, et al
    Assessment of the quality of anti-tuberculosis medicines in Almaty, Kazakhstan, 2014.
    Int J Tuberc Lung Dis. 2017;21:1161-1168.
    PubMed     Text format     Abstract available


  182. REDDY S, Ntoyanto S, Sakadavan Y, Reddy T, et al
    Detecting Mycobacterium tuberculosis using the loop-mediated isothermal amplification test in South Africa.
    Int J Tuberc Lung Dis. 2017;21:1154-1160.
    PubMed     Text format     Abstract available


  183. YADAV R, Sharma N, Khaneja R, Agarwal P, et al
    Evaluation of the TB-LAMP assay for the rapid diagnosis of pulmonary tuberculosis in Northern India.
    Int J Tuberc Lung Dis. 2017;21:1150-1153.
    PubMed     Text format     Abstract available


  184. LIANG L, Shi R, Liu X, Yuan X, et al
    Interferon-gamma response to the treatment of active pulmonary and extra-pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:1145-1149.
    PubMed     Text format     Abstract available


  185. O'CONNOR DE, Frederix K, Saito S, Maama LB, et al
    Pulmonary tuberculosis diagnostic practices among people living with the human immunodeficiency virus in Lesotho.
    Int J Tuberc Lung Dis. 2017;21:1133-1138.
    PubMed     Text format     Abstract available


  186. SHARMA SK, Chaubey J, Singh BK, Sharma R, et al
    Drug resistance patterns among extra-pulmonary tuberculosis cases in a tertiary care centre in North India.
    Int J Tuberc Lung Dis. 2017;21:1112-1117.
    PubMed     Text format     Abstract available


  187. SCHNIPPEL K, Firnhaber C, Ndjeka N, Conradie F, et al
    Persistently high early mortality despite rapid diagnostics for drug-resistant tuberculosis cases in South Africa.
    Int J Tuberc Lung Dis. 2017;21:1106-1111.
    PubMed     Text format     Abstract available


  188. MOHR E, Daniels J, Muller O, Furin J, et al
    Missed opportunities for earlier diagnosis of rifampicin-resistant tuberculosis despite access to Xpert(R) MTB/RIF.
    Int J Tuberc Lung Dis. 2017;21:1100-1105.
    PubMed     Text format     Abstract available


  189. JIANG Y, Cao B, Ohmagari N, Wu AH, et al
    Comprehensive understanding of health-seeking behaviour among pulmonary tuberculosis patients in China.
    Int J Tuberc Lung Dis. 2017;21:1094-1099.
    PubMed     Text format     Abstract available


  190. BROWN A, Ernst P, Cambule A, Morrow M, et al
    Applying the Care Group model to tuberculosis control: findings from a community-based project in Mozambique.
    Int J Tuberc Lung Dis. 2017;21:1086-1093.
    PubMed     Text format     Abstract available


  191. WILD V, Jaff D, Shah NS, Frick M, et al
    Tuberculosis, human rights and ethics considerations along the route of a highly vulnerable migrant from sub-Saharan Africa to Europe.
    Int J Tuberc Lung Dis. 2017;21:1075-1085.
    PubMed     Text format     Abstract available


  192. DENHOLM JT
    Strategic partnerships towards tuberculosis elimination.
    Int J Tuberc Lung Dis. 2017;21:1072.
    PubMed     Text format    


  193. VARAINE F
    Tuberculosis, human rights and ethics.
    Int J Tuberc Lung Dis. 2017;21:1071.
    PubMed     Text format    


    September 2017
  194. METCALFE J, Gerona R, Wen A, Bacchetti P, et al
    An LC-MS/MS-based method to analyze the anti-tuberculosis drug bedaquiline in hair.
    Int J Tuberc Lung Dis. 2017;21:1069-1070.
    PubMed     Text format    


  195. COLLINS D, Hafidz F, Mustikawati D
    The economic burden of tuberculosis in Indonesia.
    Int J Tuberc Lung Dis. 2017;21:1041-1048.
    PubMed     Text format     Abstract available


  196. MINH HV, Mai VQ, Nhung NV, Hoi LV, et al
    Costs of providing tuberculosis diagnosis and treatment services in Viet Nam.
    Int J Tuberc Lung Dis. 2017;21:1035-1040.
    PubMed     Text format     Abstract available


  197. DUNBAR R, Naidoo P, Beyers N, Langley I, et al
    High laboratory cost predicted per tuberculosis case diagnosed with increased case finding without a triage strategy.
    Int J Tuberc Lung Dis. 2017;21:1026-1034.
    PubMed     Text format     Abstract available


  198. NATHAVITHARANA RR, Daru P, Barrera AE, Mostofa Kamal SM, et al
    FAST implementation in Bangladesh: high frequency of unsuspected tuberculosis justifies challenges of scale-up.
    Int J Tuberc Lung Dis. 2017;21:1020-1025.
    PubMed     Text format     Abstract available


  199. YOON C, Chaisson LH, Patel SM, Allen IE, et al
    Diagnostic accuracy of C-reactive protein for active pulmonary tuberculosis: a meta-analysis.
    Int J Tuberc Lung Dis. 2017;21:1013-1019.
    PubMed     Text format     Abstract available


  200. DATIKO DG, Yassin MA, Theobald SJ, Cuevas LE, et al
    A community-based isoniazid preventive therapy for the prevention of childhood tuberculosis in Ethiopia.
    Int J Tuberc Lung Dis. 2017;21:1002-1007.
    PubMed     Text format     Abstract available


  201. LIAO S, Cai C, Huo FM, Wu JN, et al
    Trends in drug-resistant tuberculosis in China: data from a clinical tuberculosis centre.
    Int J Tuberc Lung Dis. 2017;21:990-995.
    PubMed     Text format     Abstract available


  202. ZENNER D, Hafezi H, Potter J, Capone S, et al
    Effectiveness and cost-effectiveness of screening migrants for active tuberculosis and latent tuberculous infection.
    Int J Tuberc Lung Dis. 2017;21:965-976.
    PubMed     Text format     Abstract available


  203. PEDRAZZOLI D, Boccia D, Dodd PJ, Lonnroth K, et al
    Modelling the social and structural determinants of tuberculosis: opportunities and challenges.
    Int J Tuberc Lung Dis. 2017;21:957-964.
    PubMed     Text format     Abstract available


  204. CENTIS R, D'Ambrosio L, Migliori GB
    Understanding the multidrug-resistant tuberculosis epidemic in China.
    Int J Tuberc Lung Dis. 2017;21:955.
    PubMed     Text format    


    August 2017
  205. THOMAS B, Watson B, Senthil EK, Deepalakshmi A, et al
    Alcohol intervention strategy among tuberculosis patients: a pilot study from South India.
    Int J Tuberc Lung Dis. 2017;21:947-952.
    PubMed     Text format     Abstract available


  206. DESHMUKH PR, Mundra A, Dawale A
    Social capital and adverse treatment outcomes of tuberculosis: a case-control study.
    Int J Tuberc Lung Dis. 2017;21:941-946.
    PubMed     Text format     Abstract available


  207. RODRIGUEZ CA, Sasse S, Yuengling KA, Azzawi S, et al
    A systematic review of national policies for the management of persons exposed to tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:935-940.
    PubMed     Text format     Abstract available


  208. SOUSA M, Gomes M, Gaio AR, Duarte R, et al
    Nosocomial tuberculosis prevention in Portuguese hospitals: a cross-sectional evaluation.
    Int J Tuberc Lung Dis. 2017;21:930-934.
    PubMed     Text format     Abstract available


  209. MCDANIEL CJ, Chitnis AS, Barry PM, Shah N, et al
    Tuberculosis trends in California correctional facilities, 1993-2013.
    Int J Tuberc Lung Dis. 2017;21:922-929.
    PubMed     Text format     Abstract available


  210. RAJAN JV, Ferrazoli L, Waldman EA, Simonsen V, et al
    Diabetes increases the risk of recent-transmission tuberculosis in household contacts in Sao Paulo, Brazil.
    Int J Tuberc Lung Dis. 2017;21:916-921.
    PubMed     Text format     Abstract available


  211. MEHRA M, Kambili C, Potluri R, Rhines A, et al
    Modeling the impact of bedaquiline treatment strategies on the multidrug-resistant tuberculosis burden in India.
    Int J Tuberc Lung Dis. 2017;21:902-909.
    PubMed     Text format     Abstract available


  212. CALDERON RI, Velasquez GE, Becerra MC, Zhang Z, et al
    Prevalence of pyrazinamide resistance and Wayne assay performance analysis in a tuberculosis cohort in Lima, Peru.
    Int J Tuberc Lung Dis. 2017;21:894-901.
    PubMed     Text format     Abstract available


  213. MELENDEZ J, Philipsen RHHM, Chanda-Kapata P, Sunkutu V, et al
    Automatic versus human reading of chest X-rays in the Zambia National Tuberculosis Prevalence Survey.
    Int J Tuberc Lung Dis. 2017;21:880-886.
    PubMed     Text format     Abstract available


  214. BONNET M, Kyakwera C, Kyomugasho N, Atwine D, et al
    Prospective cohort study of the feasibility and yield of household child tuberculosis contact screening in Uganda.
    Int J Tuberc Lung Dis. 2017;21:862-868.
    PubMed     Text format     Abstract available


  215. SWEETLAND AC, Kritski A, Oquendo MA, Sublette ME, et al
    Addressing the tuberculosis-depression syndemic to end the tuberculosis epidemic.
    Int J Tuberc Lung Dis. 2017;21:852-861.
    PubMed     Text format     Abstract available


  216. KUNST H, Burman M, Arnesen TM, Fiebig L, et al
    Tuberculosis and latent tuberculous infection screening of migrants in Europe: comparative analysis of policies, surveillance systems and results.
    Int J Tuberc Lung Dis. 2017;21:840-851.
    PubMed     Text format     Abstract available


  217. SHAKOOR S, Hasan R
    Strategies for management of latent tuberculosis in endemic settings: building evidence.
    Int J Tuberc Lung Dis. 2017;21:836.
    PubMed     Text format    


  218. ZELLWEGER JP, Posey DL
    Migrant screening for tuberculosis and LTBI in Europe.
    Int J Tuberc Lung Dis. 2017;21:835.
    PubMed     Text format    


  219. WANG XH, Ma AG, Han XX, Chen L, et al
    Relationship between Toll-like receptor 4 and type-2 diabetes mellitus complicated by tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:910-915.
    PubMed     Text format     Abstract available


    July 2017
  220. HARRIES AD, Ade S, Hoa NB, Satyanarayana S, et al
    Use of inhaled corticosteroids for obstructive lung disease following anti-tuberculosis treatment.
    Int J Tuberc Lung Dis. 2017;21:833-834.
    PubMed     Text format    


  221. MOHAMED EI, Mohamed MA, Moustafa MH, Abdel-Mageed SM, et al
    Qualitative analysis of biological tuberculosis samples by an electronic nose-based artificial neural network.
    Int J Tuberc Lung Dis. 2017;21:810-817.
    PubMed     Text format     Abstract available


  222. OH KH, Choi H, Kim EJ, Kim HJ, et al
    Depression and risk of tuberculosis: a nationwide population-based cohort study.
    Int J Tuberc Lung Dis. 2017;21:804-809.
    PubMed     Text format     Abstract available


  223. NERY JS, Rodrigues LC, Rasella D, Aquino R, et al
    Effect of Brazil's conditional cash transfer programme on tuberculosis incidence.
    Int J Tuberc Lung Dis. 2017;21:790-796.
    PubMed     Text format     Abstract available


  224. APOLINARIO D, Ribeiro AI, Krainski E, Sousa P, et al
    Tuberculosis inequalities and socio-economic deprivation in Portugal.
    Int J Tuberc Lung Dis. 2017;21:784-789.
    PubMed     Text format     Abstract available


  225. ZHU L, Yang YZ, Guan HY, Cheng SM, et al
    Trends in drug-resistant tuberculosis after the implementation of the DOTS strategy in Shenzhen, China, 2000-2013.
    Int J Tuberc Lung Dis. 2017;21:759-765.
    PubMed     Text format     Abstract available


  226. THI SS, Parker DM, Swe LL, Pukrittayakamee S, et al
    Migration histories of multidrug-resistant tuberculosis patients from the Thailand-Myanmar border, 2012-2014.
    Int J Tuberc Lung Dis. 2017;21:753-758.
    PubMed     Text format     Abstract available


  227. SHETE PB, Nalugwa T, Farr K, Ojok C, et al
    Feasibility of a streamlined tuberculosis diagnosis and treatment initiation strategy.
    Int J Tuberc Lung Dis. 2017;21:746-752.
    PubMed     Text format     Abstract available


  228. DOUGLAS P, Posey DL, Zenner D, Robson J, et al
    Capacity strengthening through pre-migration tuberculosis screening programmes: IRHWG experiences.
    Int J Tuberc Lung Dis. 2017;21:737-745.
    PubMed     Text format     Abstract available


  229. DARA M, Sulis G, Centis R, D'Ambrosio L, et al
    Cross-border collaboration for improved tuberculosis prevention and care: policies, tools and experiences.
    Int J Tuberc Lung Dis. 2017;21:727-736.
    PubMed     Text format     Abstract available


  230. KUNST H
    Cross-border collaboration in tuberculosis prevention and care in Europe: can we do better?
    Int J Tuberc Lung Dis. 2017;21:717.
    PubMed     Text format    


    June 2017
  231. MAGEE MJ, Darchia L, Kipiani M, Chakhaia T, et al
    Smoking behavior and beliefs about the impact of smoking on anti-tuberculosis treatment among health care workers.
    Int J Tuberc Lung Dis. 2017 Jun 29. doi: 10.5588/ijtld.17.0023.
    PubMed     Text format     Abstract available


  232. DELGADO E, Monedero I, Bhavaraju R
    Resilience and extensively drug-resistant tuberculosis: the unlikely ally.
    Int J Tuberc Lung Dis. 2017;21:713-716.
    PubMed     Text format     Abstract available


  233. SIVAKUMAR P, Marples L, Breen R, Ahmed L, et al
    The diagnostic utility of pleural fluid adenosine deaminase for tuberculosis in a low prevalence area.
    Int J Tuberc Lung Dis. 2017;21:697-701.
    PubMed     Text format     Abstract available


  234. TELISINGHE L, Amofa-Sekyi M, Maluzi K, Kaluba-Milimo D, et al
    The sensitivity of the QuantiFERON(R)-TB Gold Plus assay in Zambian adults with active tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:690-696.
    PubMed     Text format     Abstract available


  235. BARR DA, Coussens AK, Irvine S, Ritchie ND, et al
    Paradoxical upgrading reaction in extra-pulmonary tuberculosis: association with vitamin D therapy.
    Int J Tuberc Lung Dis. 2017;21:677-683.
    PubMed     Text format     Abstract available


  236. VAN DER HEIJDEN YF, Karim F, Mufamadi G, Zako L, et al
    Isoniazid-monoresistant tuberculosis is associated with poor treatment outcomes in Durban, South Africa.
    Int J Tuberc Lung Dis. 2017;21:670-676.
    PubMed     Text format     Abstract available


  237. PATSCHE CB, Rudolf F, Mogensen SW, Sifna A, et al
    Low prevalence of malnourishment among household contacts of patients with tuberculosis in Guinea-Bissau.
    Int J Tuberc Lung Dis. 2017;21:664-669.
    PubMed     Text format     Abstract available


  238. STENNIS NL, Meissner JS, Bhavnani D, Kreiswirth B, et al
    Tuberculosis disease among Mexico-born individuals living in New York City, 2001-2014.
    Int J Tuberc Lung Dis. 2017;21:657-663.
    PubMed     Text format     Abstract available


  239. SNOW K, Hesseling AC, Naidoo P, Graham SM, et al
    Tuberculosis in adolescents and young adults: epidemiology and treatment outcomes in the Western Cape.
    Int J Tuberc Lung Dis. 2017;21:651-657.
    PubMed     Text format     Abstract available


  240. KALRA A
    Care seeking and treatment related delay among childhood tuberculosis patients in Delhi, India.
    Int J Tuberc Lung Dis. 2017;21:645-650.
    PubMed     Text format     Abstract available


  241. ZIEMELE B, Ranka R, Ozere I
    Pediatric and adolescent tuberculosis in Latvia, 2011-2014: case detection, diagnosis and treatment.
    Int J Tuberc Lung Dis. 2017;21:637-645.
    PubMed     Text format     Abstract available


  242. LONNROTH K, Mor Z, Erkens C, Bruchfeld J, et al
    Tuberculosis in migrants in low-incidence countries: epidemiology and intervention entry points.
    Int J Tuberc Lung Dis. 2017;21:624-637.
    PubMed     Text format     Abstract available


  243. DHAVAN P, Dias HM, Creswell J, Weil D, et al
    An overview of tuberculosis and migration.
    Int J Tuberc Lung Dis. 2017;21:610-623.
    PubMed     Text format     Abstract available


  244. WALKER IF, Baral SC, Wei X, Huque R, et al
    Multidrug-resistant tuberculosis treatment programmes insufficiently consider comorbid mental disorders.
    Int J Tuberc Lung Dis. 2017;21:603-609.
    PubMed     Text format     Abstract available


  245. SEDDON JA, Gie RP
    If you look, you will find: time to challenge the childhood tuberculosis paradigm.
    Int J Tuberc Lung Dis. 2017;21:602.
    PubMed     Text format    


  246. RAVIGLIONE MC, Mosca D
    Migrant health and tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:599-600.
    PubMed     Text format    


  247. OWUSU-EDUSEI K, Stockbridge EL, Winston CA, Kolasa M, et al
    Tuberculin skin test and interferon-gamma release assay use among privately insured persons in the United States.
    Int J Tuberc Lung Dis. 2017;21:684-689.
    PubMed     Text format     Abstract available


    May 2017
  248. J-Y FENG JY, Jarlsberg LG, Salcedo K, Rose J, et al
    Clinical and bacteriological characteristics associated with clustering of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2017 May 16. doi: 10.5588/ijtld.16.0510.
    PubMed     Text format     Abstract available


  249. ARSCOTT-MILLS T, Masole L, Ncube R, Steenhoff AP, et al
    Survey of health care worker knowledge about childhood tuberculosis in high-burden centers in Botswana.
    Int J Tuberc Lung Dis. 2017;21:586-591.
    PubMed     Text format     Abstract available


  250. SCOTT C, Mangan J, Tillova Z, Jensen PA, et al
    Evaluation of the Tuberculosis Infection Control Training Center, Tajikistan, 2014-2015.
    Int J Tuberc Lung Dis. 2017;21:579-585.
    PubMed     Text format     Abstract available


  251. ADAMS LV, Basu D, Grande SW, Craig SR, et al
    Barriers to tuberculosis care delivery among miners and their families in South Africa: an ethnographic study.
    Int J Tuberc Lung Dis. 2017;21:571-578.
    PubMed     Text format     Abstract available


  252. UKWAJA KN, Alobu I, Gidado M, Onazi O, et al
    Economic support intervention improves tuberculosis treatment outcomes in rural Nigeria.
    Int J Tuberc Lung Dis. 2017;21:564-570.
    PubMed     Text format     Abstract available


  253. LOVEDAY M, Ramjee A, Osburn G, Master I, et al
    Drug-resistant tuberculosis in patients with minimal symptoms: favourable outcomes in the absence of treatment.
    Int J Tuberc Lung Dis. 2017;21:556-563.
    PubMed     Text format     Abstract available


  254. DALE KD, Globan M, Tay EL, Trauer JM, et al
    Recurrence of tuberculosis in a low-incidence setting without directly observed treatment: Victoria, Australia, 2002-2014.
    Int J Tuberc Lung Dis. 2017;21:550-555.
    PubMed     Text format     Abstract available


  255. MAHARAJ B, Gengiah TN, Yende-Zuma N, Gengiah S, et al
    Implementing isoniazid preventive therapy in a tuberculosis treatment-experienced cohort on ART.
    Int J Tuberc Lung Dis. 2017;21:537-543.
    PubMed     Text format     Abstract available


  256. SSENGOOBA W, Lukoye D, Meehan CJ, Kateete DP, et al
    Tuberculosis resistance-conferring mutations with fitness cost among HIV-positive individuals in Uganda.
    Int J Tuberc Lung Dis. 2017;21:531-536.
    PubMed     Text format     Abstract available


  257. SATAKE Y, Nakamura Y, Kono M, Hozumi H, et al
    Type-1 polarised dendritic cells are a potent immunogen against Mycobacterium tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:523-530.
    PubMed     Text format     Abstract available


  258. RONALD LA, Ling DI, FitzGerald JM, Schwartzman K, et al
    Validated methods for identifying tuberculosis patients in health administrative databases: systematic review.
    Int J Tuberc Lung Dis. 2017;21:517-522.
    PubMed     Text format     Abstract available


  259. FENG JY, Jarlsberg LG, Rose J, Grinsdale JA, et al
    Impact of Euro-American sublineages of Mycobacterium tuberculosis on new infections among named contacts.
    Int J Tuberc Lung Dis. 2017;21:509-516.
    PubMed     Text format     Abstract available


  260. HO J, Jelfs P, Nguyen PT, Sintchenko V, et al
    Pooling sputum samples to improve the feasibility of Xpert(R) MTB/RIF in systematic screening for tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:503-508.
    PubMed     Text format     Abstract available


  261. VAN AART C, Boshuizen H, Dekkers A, Korthals Altes H, et al
    Time lag between immigration and tuberculosis rates in immigrants in the Netherlands: a time-series analysis.
    Int J Tuberc Lung Dis. 2017;21:486-492.
    PubMed     Text format     Abstract available


  262. POSEY DL, Marano N, Cetron MS
    Cross-border solutions needed to address tuberculosis in migrating populations.
    Int J Tuberc Lung Dis. 2017;21:485-486.
    PubMed     Text format    


  263. YATES TA, Atkinson SH
    Ironing out sex differences in tuberculosis prevalence.
    Int J Tuberc Lung Dis. 2017;21:483-484.
    PubMed     Text format    


  264. WORTHAM JM, Goggin M, Mora C, Vandehey L, et al
    Acute kidney injury during treatment for latent tuberculous infection with rifampin.
    Int J Tuberc Lung Dis. 2017;21:596-597.
    PubMed     Text format     Abstract available


  265. LANGE B, Khan P, Kalmambetova G, Al-Darraji HA, et al
    Diagnostic accuracy of the Xpert((R)) MTB/RIF cycle threshold level to predict smear positivity: a meta-analysis.
    Int J Tuberc Lung Dis. 2017;21:493-502.
    PubMed     Text format     Abstract available


    April 2017
  266. JAIN A, Singh PK, Singh U, Kumar V, et al
    Initial screening of extra-pulmonary tuberculosis using the Xpert MTB/RIF assay improves case detection rates.
    Int J Tuberc Lung Dis. 2017;21:478-480.
    PubMed     Text format    


  267. CHONG SG, Herron M, Dorman A, Little M, et al
    Renal amyloidosis complicating multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:476-477.
    PubMed     Text format    


  268. BLOK L, Bakker MI, Straetemans M, Gerstel L, et al
    Should active case-finding projects increase the number of tuberculosis cases notified at national level?
    Int J Tuberc Lung Dis. 2017;21:475.
    PubMed     Text format    


  269. WEBER SF, Belard S, Rai S, Reddy R, et al
    Immune thrombocytopenia secondary to tuberculosis: a case and review of literature.
    Int J Tuberc Lung Dis. 2017;21:466-470.
    PubMed     Text format     Abstract available


  270. VALENCIA S, Respeito D, Blanco S, Ribeiro RM, et al
    Tuberculosis drug resistance in Southern Mozambique: results of a population-level survey in the district of Manhica.
    Int J Tuberc Lung Dis. 2017;21:446-451.
    PubMed     Text format     Abstract available


  271. ADLER H, Archary M, Mahabeer P, LaRussa P, et al
    Tuberculosis in HIV-infected South African children with complicated severe acute malnutrition.
    Int J Tuberc Lung Dis. 2017;21:438-445.
    PubMed     Text format     Abstract available


  272. CARTER KL, Gabrellas AD, Shah S, Garland JM, et al
    Improved latent tuberculosis therapy completion rates in refugee patients through use of a clinical pharmacist.
    Int J Tuberc Lung Dis. 2017;21:432-437.
    PubMed     Text format     Abstract available


  273. ARMENTA RF, Collins KM, Strathdee SA, Bulterys MA, et al
    Mycobacterium tuberculosis infection among persons who inject drugs in San Diego, California.
    Int J Tuberc Lung Dis. 2017;21:425-431.
    PubMed     Text format     Abstract available


  274. SHAIKH N, Gupte A, Dharmshale S, Pokkali S, et al
    Novel interferon-gamma assays for diagnosing tuberculosis in young children in India.
    Int J Tuberc Lung Dis. 2017;21:412-419.
    PubMed     Text format     Abstract available


  275. VAN WYK SS, Lin HH, Claassens MM
    A systematic review of prediction models for prevalent pulmonary tuberculosis in adults.
    Int J Tuberc Lung Dis. 2017;21:405-411.
    PubMed     Text format     Abstract available


  276. OWUSU-EDUSEI K, Marks SM, Miramontes R, Stockbridge EL, et al
    Tuberculosis hospitalization expenditures per patient from private health insurance claims data, 2010-2014.
    Int J Tuberc Lung Dis. 2017;21:398-404.
    PubMed     Text format     Abstract available


  277. RUPERT S, Vassall A, Raizada N, Khaparde SD, et al
    Bottom-up or top-down: unit cost estimation of tuberculosis diagnostic tests in India.
    Int J Tuberc Lung Dis. 2017;21:375-380.
    PubMed     Text format     Abstract available


  278. PANDEY S, Chadha VK, Laxminarayan R, Arinaminpathy N, et al
    Estimating tuberculosis incidence from primary survey data: a mathematical modeling approach.
    Int J Tuberc Lung Dis. 2017;21:366-374.
    PubMed     Text format     Abstract available


  279. DODD PJ
    Tracking tuberculosis incidence: time to tool up.
    Int J Tuberc Lung Dis. 2017;21:363.
    PubMed     Text format    


  280. ADINARAYANAN S, Culp RK, Subramani R, Abbas KM, et al
    Role of bacille Calmette-Guerin in preventing tuberculous infection.
    Int J Tuberc Lung Dis. 2017;21:420-424.
    PubMed     Text format     Abstract available


  281. ACUNA-VILLAORDUNA C, Orikiriza P, Nyehangane D, White LF, et al
    Effect of previous treatment and sputum quality on diagnostic accuracy of Xpert((R)) MTB/RIF.
    Int J Tuberc Lung Dis. 2017;21:389-397.
    PubMed     Text format     Abstract available


  282. DUNBAR R, Naidoo P, Beyers N, Langley I, et al
    Operational modelling: the mechanisms influencing TB diagnostic yield in an Xpert((R)) MTB/RIF-based algorithm.
    Int J Tuberc Lung Dis. 2017;21:381-388.
    PubMed     Text format     Abstract available


    March 2017
  283. ZHANG ZX, Sng LH, Yong Y, Lin LM, et al
    Delays in diagnosis and treatment of pulmonary tuberculosis in AFB smear-negative patients with pneumonia.
    Int J Tuberc Lung Dis. 2017 Mar 16. doi: 10.5588/ijtld.16.0667.
    PubMed     Text format     Abstract available


  284. MASJEDI MR, Hosseini M, Aryanpur M, Mortaz E, et al
    The effects of smoking on treatment outcome in patients newly diagnosed with pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:351-356.
    PubMed     Text format     Abstract available


  285. BOONYAGARS L, Hirunwiwatkul P, Hurst CP
    CD4 count and risk of anti-tuberculosis drug-associated cutaneous reactions in HIV-infected Thai patients.
    Int J Tuberc Lung Dis. 2017;21:338-344.
    PubMed     Text format     Abstract available


  286. DIAS M, Gaio R, Sousa P, Abranches M, et al
    Tuberculosis among the homeless: should we change the strategy?
    Int J Tuberc Lung Dis. 2017;21:327-332.
    PubMed     Text format     Abstract available


  287. O'HARA LM, Yassi A, Bryce EA, van Rensburg AJ, et al
    Infection control and tuberculosis in health care workers: an assessment of 28 hospitals in South Africa.
    Int J Tuberc Lung Dis. 2017;21:320-326.
    PubMed     Text format     Abstract available


  288. HUERGA H, Bastard M, Kamene M, Wanjala S, et al
    Outcomes from the first multidrug-resistant tuberculosis programme in Kenya.
    Int J Tuberc Lung Dis. 2017;21:314-319.
    PubMed     Text format     Abstract available


  289. JAVAID A, Hasan R, Zafar A, Chaudry MA, et al
    Pattern of first- and second-line drug resistance among pulmonary tuberculosis retreatment cases in Pakistan.
    Int J Tuberc Lung Dis. 2017;21:303-308.
    PubMed     Text format     Abstract available


  290. FOX GJ, Anh NT, Nhung NV, Loi NT, et al
    Latent tuberculous infection in household contacts of multidrug-resistant and newly diagnosed tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:297-302.
    PubMed     Text format     Abstract available


  291. KAMAKIA R, Kiazyk S, Waruk J, Meyers A, et al
    Potential biomarkers associated with discrimination between latent and active pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:278-285.
    PubMed     Text format     Abstract available


  292. NAUSCH N, Lundtoft C, Schulz G, Henckel H, et al
    Multiple cytokines for the detection of Mycobacterium tuberculosis infection in children with tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:270-277.
    PubMed     Text format     Abstract available


  293. DONNAN EJ, Coulter C, Simpson G, Clark J, et al
    Paediatric tuberculosis in Queensland, Australia: overrepresentation of cross-border and Indigenous children.
    Int J Tuberc Lung Dis. 2017;21:263-269.
    PubMed     Text format     Abstract available


  294. CRANMER LM, Langat A, Ronen K, McGrath CJ, et al
    Integrating tuberculosis screening in Kenyan Prevention of Mother-To-Child Transmission programs.
    Int J Tuberc Lung Dis. 2017;21:256-262.
    PubMed     Text format     Abstract available


  295. REICHMAN LB
    The tuberculosis taboo.
    Int J Tuberc Lung Dis. 2017;21:251-255.
    PubMed     Text format     Abstract available


  296. KURBANIYAZOVA G, Joncevska M, Kalon S, Kalmambetova G, et al
    Results of Xpert((R)) MTB/RIF implementation in Kyrgyzstan.
    Int J Tuberc Lung Dis. 2017;21:333-337.
    PubMed     Text format     Abstract available


  297. ANASTASAKOS V, Skouras V, Moschos C, Tsikrika S, et al
    Patterns of drug resistance among patients with tuberculous pleural effusion in Greece.
    Int J Tuberc Lung Dis. 2017;21:309-313.
    PubMed     Text format     Abstract available


  298. MORO RN, Sterling TR, Saukkonen J, Vernon A, et al
    Factors associated with non-completion of follow-up: 33-month latent tuberculous infection treatment trial.
    Int J Tuberc Lung Dis. 2017;21:286-296.
    PubMed     Text format     Abstract available


    February 2017
  299. PRIYADARSHINI P, Tiwari K, Das A, Kumar D, et al
    Evaluation of highly conserved hsp65-specific nested PCR primers for diagnosing Mycobacterium tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:214-217.
    PubMed     Text format     Abstract available


  300. MCEBULA V, Crowther NJ, Nagel SE, George JA, et al
    Diabetes and abnormal glucose tolerance in subjects with tuberculosis in a South African urban center.
    Int J Tuberc Lung Dis. 2017;21:208-213.
    PubMed     Text format     Abstract available


  301. BRYLA M, Dziankowska-Zaborszczyk E, Maniecka-Bryla I
    Standard expected years of life lost due to tuberculosis in Poland.
    Int J Tuberc Lung Dis. 2017;21:202-207.
    PubMed     Text format     Abstract available


  302. CLAASSENS MM, Dunbar R, Yang B, Lombard CJ, et al
    Scanty smears associated with initial loss to follow-up in South African tuberculosis patients.
    Int J Tuberc Lung Dis. 2017;21:196-201.
    PubMed     Text format     Abstract available


  303. IZUMI K, Ohkado A, Uchimura K, Kawatsu L, et al
    Evaluation of tuberculosis contact investigations in Japan.
    Int J Tuberc Lung Dis. 2017;21:188-195.
    PubMed     Text format     Abstract available


  304. HTET KK, Liabsuetrakul T, Thein S
    Cost-effectiveness of a new strategy to detect pulmonary tuberculosis in household contacts in Myanmar.
    Int J Tuberc Lung Dis. 2017;21:181-187.
    PubMed     Text format     Abstract available


  305. GUGLIELMETTI L, Hewison C, Avaliani Z, Hughes J, et al
    Examples of bedaquiline introduction for the management of multidrug-resistant tuberculosis in five countries.
    Int J Tuberc Lung Dis. 2017;21:167-174.
    PubMed     Text format     Abstract available


  306. CHIPINDURO M, Mateveke K, Makamure B, Ferrand RA, et al
    Stool Xpert(R) MTB/RIF test for the diagnosis of childhood pulmonary tuberculosis at primary clinics in Zimbabwe.
    Int J Tuberc Lung Dis. 2017;21:161-166.
    PubMed     Text format     Abstract available


  307. CHIANG SS, Roche S, Contreras C, Del Castillo H, et al
    Barriers to the treatment of childhood tuberculous infection and tuberculosis disease: a qualitative study.
    Int J Tuberc Lung Dis. 2017;21:154-160.
    PubMed     Text format     Abstract available


  308. LOPEZ C, Bertram-Farough A, Heywood D, Dawson L, et al
    Knowing about you: eliciting dimensions of personhood within tuberculosis care.
    Int J Tuberc Lung Dis. 2017;21:149-153.
    PubMed     Text format     Abstract available


  309. PARENT SN, Ehrlich R, Baxter V, Kannemeyer N, et al
    Participatory theatre and tuberculosis: a feasibility study with South African health care workers.
    Int J Tuberc Lung Dis. 2017;21:140-148.
    PubMed     Text format     Abstract available


  310. STAGG HR, Lipman MC, McHugh TD, Jenkins HE, et al
    Isoniazid-resistant tuberculosis: a cause for concern?
    Int J Tuberc Lung Dis. 2017;21:129-139.
    PubMed     Text format     Abstract available


  311. USDIN M, Dedicoat M, Gajraj R, Harrison P, et al
    Latent tuberculous screening of recent migrants attending language classes: a cohort study and cost analysis.
    Int J Tuberc Lung Dis. 2017;21:175-180.
    PubMed     Text format     Abstract available


    January 2017
  312. RIEDER HL, Van Deun A
    Rationale for high-dose isoniazid in the treatment of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:123-124.
    PubMed     Text format    


  313. REVES R, Benjamin R
    The cost of the failure to eliminate tuberculosis in the United States.
    Int J Tuberc Lung Dis. 2017;21:120.
    PubMed     Text format    


  314. KUMAR NP, Velayutham B, Nair D, Babu S, et al
    Angiopoietins as biomarkers of disease severity and bacterial burden in pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:93-99.
    PubMed     Text format     Abstract available


  315. DAVIS A, Terlikbayeva A, Aifah A, Hermosilla S, et al
    Risks for tuberculosis in Kazakhstan: implications for prevention.
    Int J Tuberc Lung Dis. 2017;21:86-92.
    PubMed     Text format     Abstract available


  316. SHAWENO D, Shaweno T, Trauer JM, Denholm JT, et al
    Heterogeneity of distribution of tuberculosis in Sheka Zone, Ethiopia: drivers and temporal trends.
    Int J Tuberc Lung Dis. 2017;21:79-85.
    PubMed     Text format     Abstract available


  317. KOURA KG, Trebucq A, Schwoebel V
    Do active case-finding projects increase the number of tuberculosis cases notified at national level?
    Int J Tuberc Lung Dis. 2017;21:73-78.
    PubMed     Text format     Abstract available


  318. RUDOLF F, Wagner AJ, Back FM, Gomes VF, et al
    Tuberculosis case finding and mortality prediction: added value of the clinical TBscore and biomarker suPAR.
    Int J Tuberc Lung Dis. 2017;21:67-72.
    PubMed     Text format     Abstract available


  319. RAGONNET R, Trauer JM, McBryde ES, Houben RM, et al
    Is IPT more effective in high-burden settings? Modelling the effect of tuberculosis incidence on IPT impact.
    Int J Tuberc Lung Dis. 2017;21:60-66.
    PubMed     Text format     Abstract available


  320. CHABALA C, Chongwe G, Jumbe-Marsden E, Somwe SW, et al
    Missed opportunities for screening child contacts of smear-positive tuberculosis in Zambia, a high-prevalence setting.
    Int J Tuberc Lung Dis. 2017;21:53-59.
    PubMed     Text format     Abstract available


  321. EGERE U, Togun T, Sillah A, Mendy F, et al
    Identifying children with tuberculosis among household contacts in The Gambia.
    Int J Tuberc Lung Dis. 2017;21:46-52.
    PubMed     Text format     Abstract available


  322. ZELDOW B, Kim S, McSherry G, Cotton MF, et al
    Use of antiretrovirals in HIV-infected children in a tuberculosis prevention trial: IMPAACT P1041.
    Int J Tuberc Lung Dis. 2017;21:38-45.
    PubMed     Text format     Abstract available


  323. JERENE D, Abebe W, Taye K, Suarez PG, et al
    Tuberculosis along the continuum of HIV care in a cohort of adolescents living with HIV in Ethiopia.
    Int J Tuberc Lung Dis. 2017;21:32-37.
    PubMed     Text format     Abstract available


  324. TUPASI T, Garfin AM, Mangan JM, Orillaza-Chi R, et al
    Multidrug-resistant tuberculosis patients' views of interventions to reduce treatment loss to follow-up.
    Int J Tuberc Lung Dis. 2017;21:23-31.
    PubMed     Text format     Abstract available


  325. WELDEGEBREAL S, Mebrahtu T
    Anti-tuberculosis drug resistance in Ethiopia: systematic review.
    Int J Tuberc Lung Dis. 2017;21:18-22.
    PubMed     Text format     Abstract available


  326. BANU S, Rahman MT, Ahmed S, Khatun R, et al
    Multidrug-resistant tuberculosis in Bangladesh: results from a sentinel surveillance system.
    Int J Tuberc Lung Dis. 2017;21:12-17.
    PubMed     Text format     Abstract available


  327. NOURZAD S, Jenkins HE, Milstein M, Mitnick CD, et al
    Estimating the global burden of multidrug-resistant tuberculosis among prevalent cases of tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:6-11.
    PubMed     Text format     Abstract available


  328. FURIN J, Diacon AH, Andries K
    Combating drug-resistant tuberculosis: the unexpected benefits of bedaquiline.
    Int J Tuberc Lung Dis. 2017;21:4-5.
    PubMed     Text format    


    December 2016
  329. STURKENBOOM MG, Bolhuis MS, Akkerman OW, de Lange WC, et al
    Therapeutic drug monitoring of first-line anti-tuberculosis drugs comprises more than C2h measurements.
    Int J Tuberc Lung Dis. 2016;20:1695-1696.
    PubMed     Text format    


  330. VELAYUTHAM B, Nair D, Kannan T, Padmapriyadarsini C, et al
    Factors associated with sputum culture conversion in multidrug-resistant pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1671-1676.
    PubMed     Text format     Abstract available


  331. SINGANAYAGAM A, Manalan K, Connell DW, Chalmers JD, et al
    Evaluation of serum inflammatory biomarkers as predictors of treatment outcome in pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1653-1660.
    PubMed     Text format     Abstract available


  332. EL AZBAOUI S, Sabri A, Ouraini S, Hassani A, et al
    Utility of the QuantiFERON-TB Gold In-Tube assay for the diagnosis of tuberculosis in Moroccan children.
    Int J Tuberc Lung Dis. 2016;20:1639-1646.
    PubMed     Text format     Abstract available


  333. CONNERS E, Garfein RS, Rodwell TC, Udwadia ZF, et al
    Mobility patterns of persons at risk for drug-resistant tuberculosis in Mumbai, India.
    Int J Tuberc Lung Dis. 2016;20:1633-1638.
    PubMed     Text format     Abstract available


  334. ZELNICK JR, O'Donnell MR, Ahuja SD, Chua A, et al
    Health care provider perspectives on tuberculosis care for foreign-born populations in New York City.
    Int J Tuberc Lung Dis. 2016;20:1625-1632.
    PubMed     Text format     Abstract available


  335. BRIGHT-THOMAS RJ, Gondker AR, Morris J, Ormerod LP, et al
    Drug-related hepatitis in patients treated with standard anti-tuberculosis chemotherapy over a 30-year period.
    Int J Tuberc Lung Dis. 2016;20:1621-1624.
    PubMed     Text format     Abstract available


  336. RENDELL NL, Batjargal N, Jadambaa N, Dobler CC, et al
    Risk of tuberculosis during pregnancy in Mongolia, a high incidence setting with low HIV prevalence.
    Int J Tuberc Lung Dis. 2016;20:1615-1620.
    PubMed     Text format     Abstract available


  337. MBATCHOU NGAHANE BH, Dahirou F, Tchieche C, Wandji A, et al
    Clinical characteristics and outcomes of tuberculosis in Douala, Cameroon: a 7-year retrospective cohort study.
    Int J Tuberc Lung Dis. 2016;20:1609-1614.
    PubMed     Text format     Abstract available


  338. SIROKA A, Law I, Macinko J, Floyd K, et al
    The effect of household poverty on tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1603-1608.
    PubMed     Text format     Abstract available


  339. MARGALIT I, Block C, Mor Z
    Seasonality of tuberculosis in Israel, 20012011.
    Int J Tuberc Lung Dis. 2016;20:1588-1593.
    PubMed     Text format     Abstract available


  340. JENSEN SG, Lillebaek T, Wilcke T, Pedersen MK, et al
    Impact of contact investigation and tuberculosis screening among high-risk groups in Denmark.
    Int J Tuberc Lung Dis. 2016;20:1580-1587.
    PubMed     Text format     Abstract available


  341. CASTRO KG
    Detection and treatment of persons with latent tuberculosis infection: first eliminate the policy-to-practice gap.
    Int J Tuberc Lung Dis. 2016;20:1565.
    PubMed     Text format    


  342. TALAVERA-PAULIN M, Garcia-Morales L, Ruiz-Sanchez BP, Caamal-Ley AD, et al
    Active tuberculosis patients have high levels of IgA anti-alpha-crystallin and isocitrate lyase proteins.
    Int J Tuberc Lung Dis. 2016;20:1681-1688.
    PubMed     Text format     Abstract available


  343. EL AZBAOUI S, Sabri A, Ouraini S, Hassani A, et al
    Utility of the QuantiFERON(R)-TB Gold In-Tube assay for the diagnosis of tuberculosis in Moroccan children.
    Int J Tuberc Lung Dis. 2016;20:1639-1646.
    PubMed     Text format     Abstract available


  344. MBATCHOU NGAHANE BH, Dahirou F, Tchieche C, Wandji A, et al
    Clinical characteristics and outcomes of tuberculosis in Douala, Cameroon: a 7-year retrospective cohort study.
    Int J Tuberc Lung Dis. 2016;20:1609-1614.
    PubMed     Text format     Abstract available


  345. MARGALIT I, Block C, Mor Z
    Seasonality of tuberculosis in Israel, 2001-2011.
    Int J Tuberc Lung Dis. 2016;20:1588-1593.
    PubMed     Text format     Abstract available


  346. BRUGUERAS S, Orcau A, Millet JP, Espinosa L, et al
    Tuberculosis clinical units improve contact tracing.
    Int J Tuberc Lung Dis. 2016;20:1572-1579.
    PubMed     Text format     Abstract available


  347. O'DONNELL MR, Padayatchi N, Metcalfe JZ
    Elucidating the role of clofazimine for the treatment of tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:52-57.
    PubMed     Text format     Abstract available


  348. NUERMBERGER E
    Evolving strategies for dose optimization of linezolid for treatment of tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:48-51.
    PubMed     Text format     Abstract available


  349. STERLING TR
    Fluoroquinolones for the treatment and prevention of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:42-47.
    PubMed     Text format     Abstract available


  350. MURRAY S, Mendel C, Spigelman M
    TB Alliance regimen development for multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:38-41.
    PubMed     Text format     Abstract available


  351. GUPTA R, Wells CD, Hittel N, Hafkin J, et al
    Delamanid in the treatment of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:33-37.
    PubMed     Text format     Abstract available


  352. MILSTEIN M, Brzezinski A, Varaine F, Mitnick CD, et al
    (Re)moving the needle: prospects for all-oral treatment for multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:18-23.
    PubMed     Text format     Abstract available


    November 2016
  353. DHOLAKIA Y, Mistry N
    Active tuberculosis case finding in a migrant slum community, Mumbai, India.
    Int J Tuberc Lung Dis. 2016;20:1562.
    PubMed     Text format    


  354. LEVIN A, Sklyuev S, Felker I, Tceymach E, et al
    Endobronchial valve treatment of destructive multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1539-1545.
    PubMed     Text format     Abstract available


  355. PINA RZ, Caleffi-Ferracioli KR, Campanerut-Sa PA, Ghiraldi-Lopez LD, et al
    Pyrazinamide susceptibility testing in Mycobacterium tuberculosis using the fast resazurin microtiter assay plate.
    Int J Tuberc Lung Dis. 2016;20:1535-1538.
    PubMed     Text format     Abstract available


  356. ALIPANAH N, Cattamanchi A, Menzies R, Hopewell PC, et al
    Treatment of non-cavitary pulmonary tuberculosis with shortened fluoroquinolone-based regimens: a meta-analysis.
    Int J Tuberc Lung Dis. 2016;20:1522-1528.
    PubMed     Text format     Abstract available


  357. KIM CH, Lim JK, Lee DH, Yoo SS, et al
    Outcomes of standard and tailored anti-tuberculosis regimens in patients with tuberculous pleural effusion.
    Int J Tuberc Lung Dis. 2016;20:1516-1521.
    PubMed     Text format     Abstract available


  358. IGLECIAS LM, Puga MA, Pompilio MA, Teles SA, et al
    Epidemiological study of hepatitis B virus among prisoners with active tuberculosis in Central Brazil.
    Int J Tuberc Lung Dis. 2016;20:1509-1515.
    PubMed     Text format     Abstract available


  359. IZUMI K, Kawatsu L, Ohkado A, Uchimura K, et al
    Evaluating the impact of health resource reconstruction on improving spatial accessibility of tuberculosis care.
    Int J Tuberc Lung Dis. 2016;20:1501-1508.
    PubMed     Text format     Abstract available


  360. LOPEZ AL, Aldaba JG, Ama CG, Sylim PG, et al
    Surveillance for tuberculosis in a rural community in The Philippines.
    Int J Tuberc Lung Dis. 2016;20:1495-1500.
    PubMed     Text format     Abstract available


  361. NOESKE J, Nana Yakam A, Abena Foe JL
    Epidemiology of tuberculosis in Cameroon as mirrored in notification data, 2006-2014.
    Int J Tuberc Lung Dis. 2016;20:1489-1494.
    PubMed     Text format     Abstract available


  362. DAFTARY A, Padayatchi N
    Provider perspectives on drug-resistant tuberculosis and human immunodeficiency virus care in South Africa: a qualitative case study.
    Int J Tuberc Lung Dis. 2016;20:1483-1488.
    PubMed     Text format     Abstract available


  363. MIBEI DJ, Kiarie JW, Wairia A, Kamene M, et al
    Treatment outcomes of drug-resistant tuberculosis patients in Kenya.
    Int J Tuberc Lung Dis. 2016;20:1477-1482.
    PubMed     Text format     Abstract available


  364. GARCIA-PRATS AJ, du Plessis L, Draper HR, Burger A, et al
    Outcome of culture-confirmed isoniazid-resistant rifampicin-susceptible tuberculosis in children.
    Int J Tuberc Lung Dis. 2016;20:1469-1476.
    PubMed     Text format     Abstract available


  365. CHAYA S, Dangor Z, Solomon F, Nzenze SA, et al
    Incidence of tuberculosis meningitis in a high HIV prevalence setting: time-series analysis from 2006 to 2011.
    Int J Tuberc Lung Dis. 2016;20:1457-1462.
    PubMed     Text format     Abstract available


  366. TURKOVA A, Chappell E, Chalermpantmetagul S, Negra MD, et al
    Tuberculosis in HIV-infected children in Europe, Thailand and Brazil: paediatric TB-HIV EuroCoord study.
    Int J Tuberc Lung Dis. 2016;20:1448-1456.
    PubMed     Text format     Abstract available


  367. JAGANATH D, Lamichhane G, Shah M
    Carbapenems against Mycobacterium tuberculosis: a review of the evidence.
    Int J Tuberc Lung Dis. 2016;20:1436-1447.
    PubMed     Text format     Abstract available


  368. UPLEKAR M
    Public-private mix for tuberculosis care and prevention. What progress? What prospects?
    Int J Tuberc Lung Dis. 2016;20:1424-1429.
    PubMed     Text format     Abstract available


    October 2016
  369. NUNN A, Tweed C
    Treatment regimens for rifampicin-resistant tuberculosis: highlighting a research gap.
    Int J Tuberc Lung Dis. 2016;20:1418-1419.
    PubMed     Text format    


  370. KARAKAS A, Turhan V, Esquinas AM
    Reasons for high mortality rates in patients with pulmonary tuberculosis needing mechanical ventilation.
    Int J Tuberc Lung Dis. 2016;20:1416-1417.
    PubMed     Text format    


  371. FRIEDEN TR
    Positive bacteriological results among contacts of patients with active tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1416.
    PubMed     Text format    


  372. NAIDOO P, Dunbar R, du Toit E, van Niekerk M, et al
    Comparing laboratory costs of smear/culture and Xpert(R) MTB/RIF-based tuberculosis diagnostic algorithms.
    Int J Tuberc Lung Dis. 2016;20:1377-1385.
    PubMed     Text format     Abstract available


  373. ZHAO Q, Xiao X, Lu W, Qiu LX, et al
    Screening diabetes in tuberculosis patients in eastern rural China: a community-based cross-sectional study.
    Int J Tuberc Lung Dis. 2016;20:1370-1376.
    PubMed     Text format     Abstract available


  374. WATTANAPOKAYAKIT S, Mushiroda T, Yanai H, Wichukchinda N, et al
    NAT2 slow acetylator associated with anti-tuberculosis drug-induced liver injury in Thai patients.
    Int J Tuberc Lung Dis. 2016;20:1364-1369.
    PubMed     Text format     Abstract available


  375. THIEL BA, Bark CM, Nakibali JG, van der Kuyp F, et al
    Reader variability and validation of the Timika X-ray score during treatment of pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1358-1363.
    PubMed     Text format     Abstract available


  376. PARCHURE R, Kulkarni V, Gangakhedkar R, Swaminathan S, et al
    Treatment outcomes of daily anti-tuberculosis treatment in HIV-infected patients seeking care at a private clinic in India.
    Int J Tuberc Lung Dis. 2016;20:1348-1353.
    PubMed     Text format     Abstract available


  377. TOLLEFSON D, Ngari F, Mwakala M, Gethi D, et al
    Under-reporting of sputum smear-positive tuberculosis cases in Kenya.
    Int J Tuberc Lung Dis. 2016;20:1334-1341.
    PubMed     Text format     Abstract available


  378. SENKORO M, Kumar AM, Chinnakali P, Mfinanga SG, et al
    Population impact of factors associated with prevalent pulmonary tuberculosis in Tanzania.
    Int J Tuberc Lung Dis. 2016;20:1326-1333.
    PubMed     Text format     Abstract available


  379. ENANE LA, Lowenthal ED, Arscott-Mills T, Matlhare M, et al
    Loss to follow-up among adolescents with tuberculosis in Gaborone, Botswana.
    Int J Tuberc Lung Dis. 2016;20:1320-1325.
    PubMed     Text format     Abstract available


  380. STILLSON CH, Okatch H, Frasso R, Mazhani L, et al
    'That's when I struggle' ... Exploring challenges faced by care givers of children with tuberculosis in Botswana.
    Int J Tuberc Lung Dis. 2016;20:1314-1319.
    PubMed     Text format     Abstract available


  381. SULIS G, Gnanou S, Roggi A, Konseimbo A, et al
    Active tuberculosis case finding among pregnant women: a pilot project in Burkina Faso.
    Int J Tuberc Lung Dis. 2016;20:1306-1308.
    PubMed     Text format     Abstract available


  382. MUNANG ML, Browne C, Evans JT, Smith EG, et al
    Programmatic utility of tuberculosis cluster investigation using a social network approach in Birmingham, United Kingdom.
    Int J Tuberc Lung Dis. 2016;20:1300-1305.
    PubMed     Text format     Abstract available


  383. TEBRUEGGE M, Buonsenso D, Brinkmann F, Noguera-Julian A, et al
    European shortage of purified protein derivative and its impact on tuberculosis screening practices.
    Int J Tuberc Lung Dis. 2016;20:1293-1299.
    PubMed     Text format     Abstract available


  384. TREBUCQ A, Schwoebel V
    Numbers of tuberculosis cases: dreams and reality.
    Int J Tuberc Lung Dis. 2016;20:1288-1292.
    PubMed     Text format     Abstract available


  385. LONG R, Lau A
    How R G Ferguson's groundbreaking studies influenced our understanding of tuberculosis reinfection. Where to next?
    Int J Tuberc Lung Dis. 2016;20:1285-1287.
    PubMed     Text format    


  386. LONNROTH K, Shah NS, Lange C
    State-of-the-art series on tuberculosis and migration.
    Int J Tuberc Lung Dis. 2016;20:1280-1281.
    PubMed     Text format    


    May 2016
  387. NICOLINI A, Perazzo A, Gatto P, Piroddi IM, et al
    A rare adverse reaction to ethambutol: drug-induced haemolytic anaemia.
    Int J Tuberc Lung Dis. 2016;20:704-5.
    PubMed     Text format     Abstract available


  388. MUKHERJEE A, Velpandian T, Singla M, Kanhiya K, et al
    Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in HIV-infected Indian children.
    Int J Tuberc Lung Dis. 2016;20:666-72.
    PubMed     Text format     Abstract available


  389. RUAN YZ, Li RZ, Wang XX, Wang LX, et al
    The affordability for patients of a new universal MDR-TB coverage model in China.
    Int J Tuberc Lung Dis. 2016;20:638-44.
    PubMed     Text format     Abstract available


  390. MODI M, Sharma K, Sharma M, Sharma A, et al
    Multitargeted loop-mediated isothermal amplification for rapid diagnosis of tuberculous meningitis.
    Int J Tuberc Lung Dis. 2016;20:625-30.
    PubMed     Text format     Abstract available


  391. MOK Y, Tan TY, Tay TR, Wong HS, et al
    Do we need transbronchial lung biopsy if we have bronchoalveolar lavage Xpert(R) MTB/RIF?
    Int J Tuberc Lung Dis. 2016;20:619-24.
    PubMed     Text format     Abstract available


    April 2016
  392. BANDA H, Robinson R, Thomson R, Squire SB, et al
    The 'Practical Approach to Lung Health' in sub-Saharan Africa: a systematic review.
    Int J Tuberc Lung Dis. 2016;20:552-9.
    PubMed     Text format     Abstract available


  393. YU J, Wang ZJ, Chen LH, Li HH, et al
    Diagnostic accuracy of interferon-gamma release assays for tuberculous meningitis: a meta-analysis.
    Int J Tuberc Lung Dis. 2016;20:494-9.
    PubMed     Text format     Abstract available


  394. WANG F, Hou HY, Wu SJ, Zhu Q, et al
    Using the TBAg/PHA ratio in the T-SPOT((R)).TB assay to distinguish TB disease from LTBI in an endemic area.
    Int J Tuberc Lung Dis. 2016;20:487-93.
    PubMed     Text format     Abstract available


  395. SILVA AP, Hill P, Belo MT, Rabelo SG, et al
    Non-completion of latent tuberculous infection treatment among children in Rio de Janeiro State, Brazil.
    Int J Tuberc Lung Dis. 2016;20:479-86.
    PubMed     Text format     Abstract available


  396. KELLY AM, Smith B, Luo Z, Given B, et al
    Discordance between patient and clinician reports of adverse reactions to MDR-TB treatment.
    Int J Tuberc Lung Dis. 2016;20:442-7.
    PubMed     Text format     Abstract available


    March 2016
  397. COWAN J, Michel C, Manhica I, Mutaquiha C, et al
    Remote monitoring of Xpert(R) MTB/RIF testing in Mozambique: results of programmatic implementation of GxAlert.
    Int J Tuberc Lung Dis. 2016;20:335-41.
    PubMed     Text format     Abstract available


    February 2016
  398. YANG HK, Park MJ, Lee JH, Lee CT, et al
    Incidence of toxic optic neuropathy with low-dose ethambutol.
    Int J Tuberc Lung Dis. 2016;20:261-4.
    PubMed     Text format     Abstract available


  399. SIDIQ Z, Hanif M, Chopra KK, Khanna A, et al
    Random blinded rechecking of AFB smears in a pilot project at an intermediate reference laboratory.
    Int J Tuberc Lung Dis. 2016;20:252-6.
    PubMed     Text format     Abstract available


  400. MBONZE NB, Tabala M, Wenzi LK, Bakoko B, et al
    Xpert((R)) MTB/RIF for smear-negative presumptive TB: impact on case notification in DR Congo.
    Int J Tuberc Lung Dis. 2016;20:240-6.
    PubMed     Text format     Abstract available


  401. SABI I, Kabyemera R, Mshana SE, Kidenya BR, et al
    Pulmonary TB bacteriologically confirmed by induced sputum among children at Bugando Medical Centre, Tanzania.
    Int J Tuberc Lung Dis. 2016;20:228-34.
    PubMed     Text format     Abstract available


  402. ELIAS D, Akuffo H, Abate E, Mekonnen Y, et al
    Risk of tuberculous infection in adolescents and adults in a rural community in Ethiopia.
    Int J Tuberc Lung Dis. 2016;20:218-22.
    PubMed     Text format     Abstract available


  403. KERKHOFF AD, Meintjes G, Opie J, Vogt M, et al
    Anaemia in patients with HIV-associated TB: relative contributions of anaemia of chronic disease and iron deficiency.
    Int J Tuberc Lung Dis. 2016;20:193-201.
    PubMed     Text format     Abstract available


  404. BONNET M, Bastard M, du Cros P, Khamraev A, et al
    Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study.
    Int J Tuberc Lung Dis. 2016;20:177-86.
    PubMed     Text format     Abstract available


  405. NIKAM C, Patel R, Sadani M, Ajbani K, et al
    Redefining MTBDRplus test results: what do indeterminate results actually mean?
    Int J Tuberc Lung Dis. 2016;20:154-9.
    PubMed     Text format     Abstract available


  406. GLAZIOU P, Floyd K, Weil D, Raviglione M, et al
    TB deaths rank alongside HIV deaths as top infectious killer.
    Int J Tuberc Lung Dis. 2016;20:143-4.
    PubMed     Text format    


    January 2016
  407. KO Y, Lee HK, Lee YS, Kim MY, et al
    Accuracy of Xpert((R)) MTB/RIF assay compared with AdvanSure TB/NTM real-time PCR using bronchoscopy specimens.
    Int J Tuberc Lung Dis. 2016;20:115-20.
    PubMed     Text format     Abstract available


  408. BENERI CA, Aaron L, Kim S, Jean-Philippe P, et al
    Understanding NIH clinical case definitions for pediatric intrathoracic TB by applying them to a clinical trial.
    Int J Tuberc Lung Dis. 2016;20:93-100.
    PubMed     Text format     Abstract available


  409. KAPOOR S, Gupta A, Shah M
    Cost-effectiveness of isoniazid preventive therapy for HIV-infected pregnant women in India.
    Int J Tuberc Lung Dis. 2016;20:85-92.
    PubMed     Text format     Abstract available


  410. HENSEL RL, Kempker RR, Tapia J, Oladele A, et al
    Increased risk of latent tuberculous infection among persons with pre-diabetes and diabetes mellitus.
    Int J Tuberc Lung Dis. 2016;20:71-8.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: